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Abstract
Polyamine-terminated first and second generation Newkome dendrimers
possessing a perylene core were synthesised. Interactions were probed
between carbon nanotubes and the perylene core. The DNA binding ability
of the dendrimers was tested.
As with similar, non polyamine terminated perylene containing dendrimers
reported in the literature, the first generation dendrimer was shown to
solubilise carbon nanotubes.
The first generation dendrimer demonstrated a particularly high DNA
binding ability, presumably in part due to covalent and self-assembled
multivalency. Theory and observations gave cause for concern regarding the
applicability of the ethidium bromide displacement DNA binding assay to
systems containing polycyclic aromatic hydrocarbons, due to the possibility
of intercalation into the DNA double-helix. This alternate binding mode was
investigated. The second generation dendrimer exhibited slightly reduced
binding ability relative to its cationic charge, in opposition to the increase
in binding strength that would be expected due to increased covalent
multivalency, but in accordance with a reduction in intercalation and self-
assembled multivalency.
Difficulty was experienced imaging DNA by transmission electron mi-
croscopy; accordingly no direct evidence could be produced to demonstrate
the existence of DNA dendrimer CNT nano-hybrids. However, the data
indicating the formation of CNT-dendrimer complexes and dendrimer-DNA
complexes suggest that, in solution, DNA dendrimer CNT nano-hybrids
should be present. No evidence could be found to suggest that binding of the
dendrimer molecules to carbon nanotubes significantly reduced their affinity
for DNA, nor to suggest that binding of the dendrimers to DNA significantly
inhibited their CNT binding ability.
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Abbreviations and Chemical Formulae
Ac Acetate
Boc tert-butoxycarbonyl
CD Circular dichroism
CDCl3 Deuterated chloroform
CFTR Cystic fibrosis transmembrane conductance regulator
CHCl3 Chloroform
CNT Carbon nanotube
δ Chemical shift
Da Dalton/atomic mass unit, ca. 1.66 x 10−27 kg
DAPMA N,N-di-(3-aminopropyl)-N-(methyl)amine
DCC Dicyclohexylcarbodiimide
DCM Dichloromethane
DIPEA N,N-Diisopropylethylamine
DMAP 4-Dimethylaminopyridine
DMD Duchenne muscular dystrophy
d-MeOD Deuterated methanol
DMSO Dimethyl sulfoxide
dsDNA Double-stranded DNA
DNA Deoxyribonucleic acid
EthBr * Ethidium bromide
ESI Electrospray ionisation
EtOAc Ethyl acetate
f-CNT Functionalised carbon nanotube
G1, G2, ..., Gn First generation, second generation, nth generation
HCl Hydrogen chloride or hydrochloric acid
HOBt Hydroxybenzotriazole
IR Infrared
M mol dm−3
m/z Mass to charge ratio
MALDI Matrix-assisted laser desorption ionisation
Me Methyl
MeOH Methanol
mRNA Messenger RNA
MWCNT† Multi-walled carbon nanotube
NMR Nuclear magnetic resonance
PBI Perylene bisimide
PEI Polyethyleneimine
PEG Polyethylene glycol
ppm Parts per million
R f Retention factor
RNA Ribonucleic acid
SDBS Sodium dodecylbenzene sulfonate
SDS Sodium dodecyl sulphate
SWCNT‡ Single-walled carbon nanotube
T3P 2-Propanephosphonic acid anhydride
TBTU Tetramethyl-O-(benzotriazol-1-yl)uronium tetrafluoroborate
TEM Transmission electron microscopy
TFA Trifluoroacetic acid
THF Tetrahydrofuran
UV/Vis Ultraviolet/visible light
* Abbreviated in some publications as EtBr
†Abbreviated in some publications as MWNT
‡Abbreviated in some publications as SWNT
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1 Introduction
1.1 Nanohybrids
In many areas of chemistry and physics, biology is increasingly a guide and
an inspiration for further development. The formation of nanostructures
provides the opportunity to create complex systems that promise new
functionality and greater degrees of controllability. In biological systems,
nanoscale structures range from functional molecules such as proteins and
deoxyribonucleic acid (DNA) to larger, near microscale cell organelles. In
cooperation with associated cell machinery, DNA and enzymes control the
biochemical functions of the cell.
Figure 1: Three components of a carbon nanotube (top), zinc naphthalocyanine
(bottom-right) and imidazole (bottom-left) nanohybrid.1
Nanohybrids promise a means to construct complex systems from well-
defined components, many of which have well-characterised and well
understood behaviour and function. For the purpose of this thesis, we will
consider a nanohybrid to consist of two or more functionally or structurally
distinct sub units. These units, and the resulting hybrid, should be of
or near to the nanoscale, and the component parts can be bound together
either covalently or non-covalently. To illustrate this principle, non-covalent
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pi-pi stacking interactions have allowed pyrene functionalised imidazole
units to be bound to carbon nanotubes (CNTs). Zinc naphthalocyanine
can then be bound to the imidazole unit, producing a three-component
nanohybrid in which the nanotubes can be reduced by photoinduced electron
transfer from the naphthalocyanine (Figure 1).1 A similar approach has been
followed to produce a buckminsterfullerene-CNT nanohybrid via covalent
functionalisation of the fullerene unit with a pyrene moiety, and subsequent
non-covalent interaction between this pyrene and the nanotube (Figure 2).2
Figure 2: Buckminsterfullerene-CNT nanohybrid, facilitated by covalent functionali-
sation of the fullerene unit (red) with a pyrene moiety (yellow).2
The term bio-nanohybrid refers to materials containing both a biological unit
and an inorganic substrate, such as composites of layered double hydroxides
and DNA, or gold nanoparticles and chitosan.3 Nanohybrids containing both
biological molecules and organic units have also been produced, including
complexes consisting of a protein bound to a dendritic polyamine (Figure 3),
and numerous polymer-DNA or lipid-DNA complexes.4–9
2
Figure 3: Covalently-bound dendrimer-protein bio-nanohybrid, formed by the
attachment of a polyamine-terminated second-generation dendron to bovine serum
albumen.4
1.2 Nanoscale Architectures
1.2.1 Dendrimers and Dendrons
Dendrimers, historically also known as arborols or cascade molecules, are
a class of symmetrical, highly-branched polymers or oligomers. Synthesis
is an iterative process, individually adding successive layers or generations
to the molecule, allowing for control over both the degree and extent
of any branching and thus the overall molecular weight and number of
surface groups. Accordingly, unlike most typical polymers, true dendrimers
are monodisperse, providing nanoscale building-blocks of known size and
behaviour (Figure 4).
Figure 4: Well-defined, spherical dendrimer produced by an iterative synthesis.10
As with polymer derivatisation, surface-group modification of dendritic
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molecules provides for some tuneability of their interaction with other
molecules. However, the layered structure of dendritic molecules, consisting
of core, shell, and surface regions distinguishes them from polymers in that
there can be considerably more control over the spatial location of any
modifications. This allows for separation of function of the different regions
of the vector. Such specialisation has been used to create hydrophobic pockets
in a dendrimer’s shell, allowing for encapsulation of a toxic, hydrolysable
or insoluble drug molecule, while the surface was functionalised with
hydrophilic groups, facilitating solubility and biocompatibility and enabling
delivery of the drug in vivo.11 Alternatively, dendrimers can be tuned to
bind to larger molecules, with surface groups having being added that target
specific cell surface proteins,12 or cores included that are capable of binding
large synthetic molecules.13
The branching that accompanies the formation of each generation means
an exponential increase in the number of terminal groups, rapidly
producing molecules with a high-degree of multivalency. This makes
dendrimers especially suited to applications where cooperative binding
effects are beneficial or desirable, such as receptor binding in vitro where
dendritic multivalency can allow effective host-guest binding at nanomolar
concentrations.14 The formation of aggregates, either as well-defined dimers
or oligomers, or as more amorphous units, has been shown to further enhance
the binding ability of many dendrimers, in effect forming a number of non-
covalent, highly multivalent supermolecules. Control over the population of
these aggregated forms through the introduction of solvophobic moieties, or
through increasing the steric bulk of the molecule, is another tool available to
chemists, allowing encouragement or reduction of the extent to which their
dendrimers interact with each other and with other molecules in solution.
Due to their branching and symmetry, most families of dendrimers will
tend towards a spherical morphology as their mass increases (Figure 4).
In contrast, dendrons, which can be thought of as a fragment or segment
of a dendrimer, are asymmetric with a more easily accessible core. These
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characteristics allow dendritic molecules to be further optimised for a given
application.
Figure 5: Fréchet-type dendron bearing a tetracarboxylic acid core (left), and the
dendritic hexamer produced when six of these dendron units self-assemble (right).15
Interactions between complementary dendrons, or between metal ions and
multivalent ligands can produce large self-assembled dendrimers (Figure
5).15,16 This can be an end in itself, or the resulting dendrimer can then be
incorporated into larger structures. Cationic dendrimers, either covalently or
non-covalently produced, form non-specific complexes with double-stranded
DNA, with a number of possible conformations depending on the initial
morphology and degree of branching of the dendrimer, and the relative
concentrations of DNA and dendrimer.17
1.2.2 Carbon Nanotubes
On the nanoscale, there are many types of nanotubes: hollow, pseudo-one
dimensional structures with a range of unique properties due to their unusual
morphology. Tubular structures, with the atoms arranged in a manner similar
to a rolled up sheet of graphite, have been produced from carbon,18 silicon,19
and boron nitride,20 with subtle differences between these isoelectronic
analogues. Biological molecules have also been shown to form nanoscale
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tubes, with DNA having been formed into programmable structures less
than 20 nm across (Section 1.2.3). Naturally occurring structures connect
the cytoplasm of adjacent cells in both animals and plants and have been
described as nanotubes; however, possessing diameters of up to 700 nm in
animals and up to 50 nm in plants, they are considerably wider than many of
the synthetically produced structures described above.21,22
The first of these synthetic nanotubes were those formed from carbon.
Reported by Iijima in 1991, carbon nanotubes are one of several recently
discovered carbon allotropes and are closely related to other recently
discovered forms of carbon: fullerenes and graphene.18,23,24 CNTs can exist
as single layers, known as single-walled carbon nanotubes (SWCNTs), or
multiple layers nested within one another (multi-walled carbon nanotubes,
or MWCNTs), with the single-walled variant reported independently and
simultaneously in Nature by two groups in 1993.25,26 Carbon nanotubes
possess considerable tensile strength and rigidity and, when unmodified, can
act as one-dimensional wires due to their extended aromatic nature.27,28 Their
unique properties render them of great interest in the fabrication of materials
and structures across a wide range of scales.
Figure 6: Carbon nanotube, showing the extended graphitic aromatic structure.
Carbon nanotubes have been used to produce ultra-strong fibres,29 with
potential for use in macroscale structures that require otherwise unobtainable
tensile strength, such as proposed “space-elevators,”30,31 as well as being
used to reinforce polymer composites.32 On the nanoscale, carbon nanotubes
feature in numerous donor-acceptor nanohybrids, including those described
above.1,2,33 Magnetic nanoparticle-CNT hybrids have been shown to act
as improved phenol oxidation catalysts,34 while many other structural
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or functional hybrids between CNTs and a diverse array of nanoscale
components such as dendrimers, DNA, or proteins have also been reported.
Hybrids containing carbon nanotubes can be formed by both covalent
and non covalent means. Functionalising carbon nanotubes by covalent
methods typically involves either oxidation in an acidic medium or 1,3-
dipolar cycloaddition, producing substituted structures with much of the
carbon nanotubes’ unique aromatic character disrupted by the modifying
groups,35–37 although ester-branching dendritic units have been used in order
to provide the nanotubes with a high population of functional groups with
minimum covalent modification, with highly-branched dendrons “sprouting”
from relatively few sites on the CNT surface.38
Nevertheless, in some cases even this minimal disruption this may be
considered undesirable, particularly if the optoelectronic properties of the
nanotube are the focus of interest. As with many nanoscale objects, a
large proportion of carbon nanotubes’ atoms are on the surface of the
molecule - in single-walled carbon nanotubes this is the case for all of
the atoms.39 Consequently, covalent modification of the surface may have
significant effects on the properties of the bulk material. It is therefore
of great interest to explore routes that allow effective functionalisation of
the carbon nanotubes by non-covalent means, as these approaches do not
perturb the nanotubes’ aromatic framework. Such methods rely on the
CNTs’ aromatic and hydrophobic character, and in this way make available
a wide-range of functionalities and structural additions without chemically
modifying the nanotubes’ core chemical and physical structure.39 Non-
covalent functionalisation via pi-pi stacking or van der Waals interactions is,
of course, thermodynamically controlled and accordingly suggests potential
for CNT containing systems that could be tuned to respond to changes in
their chemical or physical environment.40
Interactions between carbon nanotubes and common surfactants such as
sodium dodecyl sulfate (SDS)41 or gum arabic, a widely used polysaccharide
7
Figure 7: Sodium dodecyl sulphate surfactant (bottom) and illustration of the
possible interactions between surfactant molecules and the hydrophobic CNT
surface.41
food additive32,42 allow the otherwise strongly aggregating CNTs to be
dispersed in aqueous solution (Figure 7). Aside from these lipid derivatives
or sugar based polymers, numerous other biological molecules will interact
non-covalently with carbon nanotubes. Many proteins will adsorb onto
CNTs and this has been exploited in combination with protein DNA
interactions to pattern carbon nanotubes onto a DNA scaffold.32 Direct
interactions between CNTs and single-stranded DNA (ssDNA) have been
used to create a highly selective and sensitive metal ion sensor. If the
fluorescent dye 6-carboxyfluorescein is covalently attached to thymine-rich
strands of ssDNA, DNA CNT interactions will keep the dye in close
proximity to the aromatic CNT surface, resulting in quenching of the dye’s
fluorescence. Addition of Hg2+ ions promotes the formation of a double-
stranded DNA-Hg2+ complex due to favourable thymine-mercury-thymine
(T-Hg2+-T) interactions, encouraging decomplexation of the modified ssDNA
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from the CNT surface and so increasing the total fluorescence of the dye
(Figure 8).43
Figure 8: Representation of the possible interactions between modified ssDNA and a
carbon nanotube (top-right), and between the same ssDNA and Hg2+ ions (bottom-
right), indicating the resulting change in fluorescence of the attached dye.43
Carbon nanotubes can also form complexes with many biological and non
biological species via encapsulation. Buckminsterfullerene (C60) has been
shown to enter the cavity inside CNTs, with multiple C60 units forming
a “peapod” structure. Encapsulation has also been demonstrated using
larger fullerenes, with “bucky-balls” as large as C84 having been observed
to enter CNTs. Fullerenes that themselves encapsulate metal atoms have been
encouraged to enter carbon nanotubes, creating three-component peapods in
which each “pea” contains a shielded metal. Metal salts in solution or in their
molten state have been encapsulated directly, as have metal atoms. In one
eye-catching investigation, nanoscale thermometers were produced in which
a column of liquid gallium was shown to expand linearly with temperature
while encapsulated within a carbon nanotube (Figure 9).40 Liquid water has
also been demonstrated to enter carbon nanotubes, demonstrating that the
hydrophobic environment within does not necessarily present a barrier to the
entry of predominantly hydrophilic compounds.44
Small biological molecules have been shown to enter nanotubes, as well
as adhering to the outer surface. DNA octanucleotides, for example, have
entered into the spaces inside CNTs, as have segments of RNA.32
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Figure 9: A gallium-CNT “nanothermometer,” visualised by scanning electron
microscopy, showing the changing level of the gallium meniscus at a) 58 ◦C, b) 490 ◦C,
and c) 45 ◦C.45
1.2.3 DNA
Numerous approaches have been undertaken to control and manipulate
DNA, either for the purposes of gene delivery (see Section 1.3), or
for incorporation into nanostructures. In addition to interactions with
dendrimers or with CNTs as described above, DNA tiles formed by nucleotide
base-pairing have been formed into chiral tubes and ribbons,46 while double-
stranded DNA has been used to construct rigid tetrahedra47 and truncated
octahedra,48 as well as “four-way junctions” being created by G-quadruplex
formation (Figure 10).49,50 These units could be incorporated into larger
nanohybrid complexes as scaffold units to govern structure and orientation,
or as functional units themselves.
Similar structures have been designed in which, with the covalent addition
of other groups such as thiols, form cages capable of binding gold
nanoparticles or a range of transition metals.52,53 By covalently including
protein binding ligands in a self-assembled, modified DNA nanostructure,
distance dependent cooperativity can be probed with nanometre-scale
precision,54 while triplex-DNA has been used to create nanostructures with
unique, individually addressable sites, potentially allowing sub-nanometre
targeting by nucleotide recognition (Figure 10).55
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Figure 10: Truncated octahedron (top-left)48 and a tetrahedron (top-centre)47 created
by complementary base-pairing, chiral DNA nanoribbons (top-right),46 four way
junction created by G-quadruplex formation between two double-stranded DNA
oligonucleotides (bottom-left)49 and a hexamer self-assembled from covalently
modified DNA, able to template the arrangement of gold nanoparticles (bottom
right)51
In addition to control over the placing of ligands, or nucleotide-specfic
binding, non-specific DNA complexes can be formed using a number of
techniques such as electrostatic attraction between cations and DNA’s anionic
backbone. The need for highly efficient, readily synthesisable DNA-binding
molecules becomes apparent when examining their uses in gene therapy.
1.3 Gene Therapy and DNA Binding
Gene therapy offers considerable potential as a means of treating heritable
genetic diseases, and as a novel treatment for non-hereditary diseases such
as some cancers. The various approaches all share the common aim of
introducing either modified DNA into the target cells or, in the case of
damaging mutations, introducing the naturally occurring, “wild-type” form
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of the gene. The following pages will explore some common means of gene
binding, packaging and delivery, and outline some of the processes that
must be considered when designing gene-therapeutic agents and other DNA
binding molecules.
While the genes that govern a particular process are, in many cases, identified
by correlating an error in function with an observed or induced mutation,
many have been isolated based on similarities between the encoded protein
and proteins of known function.20 It should be noted that typically, the
introduction of a working copy does not replace a defective gene, rather
the additional material complements it: coding for the desired protein
and so regulating a biochemical process that was hitherto unregulated
or incorrectly regulated. In cases where pathology results from the
production of an undesirable protein, or an otherwise acceptable protein in
undesirable amounts, the gene’s expression could, theoretically, be inhibited
by introducing DNA or RNA complementary to the messenger RNA (mRNA)
complicit in the production of the protein. The resultant double-stranded
hybrid would be unable to take part in translation of the mutant genetic
code, and the defective protein would no longer be produced.56 Recent
investigations have successfully demonstrated that double stranded short
interfering RNA (siRNA) can have a similar effect, demonstrating a reduction
of up to 50% in the expression of a specific protein.57
Mammalian cells cultured in vitro will take up DNA directly from their
growth medium, albeit only at low levels, as will yeast and plant cells if
first treated to remove their cell walls. Uptake can be promoted by preparing
the DNA as its calcium salt, by increasing membrane permeability with the
application of a high-voltage pulse, or by direct injection of DNA into the
cells’ nuclei using a fine-tipped pipette.20
Once inside the nucleus, the foreign DNA may remain distinct from the target
cell’s genetic material and is known, in this case, as an episome. Alternatively,
the new genes may be attached to the resident chromosomes by foreign
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Figure 11: Vector-mediated transfer of DNA into a cell and the resulting expression
of the gene, showing (1.) protection/complexation of the DNA with the vector of
choice, (2.) transport across the cell membrane and encapsulation of the DNA and
vector within an endosome, (3.) escape from the endosome, (4.) transport to the
nucleus and decomplexation of the DNA from the vector, and (5.) expression of the
gene, producing the desired protein.54
integrase enzymes introduced for that purpose, or by the cell’s normal DNA
repair and recombination pathways. Insertion may be site-specific or may be
seemingly random, disrupting the host cell’s genetic sequence and, in effect,
causing mutations. Such non-specific addition can interfere with the coding
of essential proteins, impairing the correct functioning of otherwise healthy
cells and, in some cases, producing carcinogenic effects. In one French trial,
several children developed a leukemia-like illness after integration of the
therapeutic DNA disrupted other, previously healthy genes.56 Alternatively,
incorporation may be of no detriment to the host cell and, in the course
of normal growth, these cells may replicate their now modified genome.
In organisms that propagate by sexual reproduction, if this new genetic
material makes its way into the gametes it will be inherited by any offspring;
something between 0.1% and 1% of the DNA of mice is formerly viral DNA
that has now become integrated into the genome.20 While the deliberate
incorporation of alien genes into somatic cells is of little social and ethical
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concern beyond the immediate medical effects, the introduction of transgenic
material into the human germ-line, leading to heritable genetic modifications,
is currently considered to be cause for caution and, accordingly, research
directly involving gene therapy using human gametes is not permitted in
most jurisdictions.56
1.3.1 Viral Vectors
There are myriad ways to improve the absorption and expression of DNA by
cells. The uptake of “naked” or untreated DNA can be increased in several
ways, including those outlined above, or by techniques such as massage of
the target organs.58 Free DNA, however, does not persist in vivo if not taken
up by cells; when incubated in blood, the majority of any unprotected DNA
will degrade within 2 hours.59 Viruses, being well adapted to transmit foreign
DNA into cells, can be used to bind and package DNA, and then to “infect”
unhealthy cells with this desirable genetic material.20 Virus based gene
therapy has been successfully used in the treatment of adenosine deaminase
deficiency (ADA), one cause of SCID (severe combined immunodeficiency,
or“’bubble-boy disease”).20,60,61 T-lymphocytes were isolated from the patient
and infected in vitro with a retrovirus bearing the working adenosine
deaminase gene. Regular injections of these transgenic immune cells led to
a significant improvement in the patient’s health. Similar ex vivo methods
have been explored for other conditions in which, as in ADA, the defect is
confined to a single gene and the pathological effect of the error is limited to
a single type of easily accessible cell.20,56
In contrast, some conditions require an in vivo approach to treatment. Cystic
fibrosis (CF) and Duchenne Muscular Dystrophy (DMD) are both frequently
presented as possible candidates for gene therapy. While both conditions
are the result of monogenic defects and would, conceivably, be treatable
through the introduction of working CFTR and dystrophin genes respectively,
in neither case are the target cells of a single type, nor are they easily
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manipulated in vitro and then reintroduced, as in blood cell disorders.56
Retroviruses & Lentiviruses
In general, retroviruses are only able to infect replicating cells, as the
viral genome must become incorporated into the target cells’ chromosomes
and is only able to do so during mitosis. This renders retroviral vectors
of little use for conditions such as CF or DMD where the target cells
replicate slowly, if at all. Lentiviruses exist as a sole exception in the
family Retroviridae, having developed the ability to replicate without the
cell division process. A lentivirus such as HIV could, therefore, be modified
and used to transduce DNA into non-dividing cells. A further difference
from the majority of retroviruses is that HIV infects only one type of cell
(specifically, T lymphocytes) due to protein interactions between the virus’
coat and the cell surface during infection. By modification of the virus
surface proteins, this specificity can be tuned to target other cells. HIV-
based vectors have been prepared in which 75 % of the original genome has
been removed in order to reduce any risk of possible pathological effects in
vivo, leaving only the genes necessary to enable the transduction of DNA
into non-dividing cells. Concerns remain, though, that the modified virus
may undergo recombination with related viruses, resulting in an infectious,
pathological hybrid.56
Adenoviruses
Rather than containing RNA, which must then be transcribed into DNA after
entry to the target cell, adenoviruses contain double-stranded DNA. Not
needing mitosis and its associated biochemical process in order to manifest
the desired genes, adenoviruses are able to infect non-replicating cells. In
cells that do go on to replicate, the additional DNA is present as distinct
episomes, rather than becoming integrated into the host cell’s DNA, reducing
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fears of germ-line contamination and oncogenic effects. Some show a degree
of specificity for the respiratory tract and, accordingly, are well suited to
treatment of cystic fibrosis. One adenovirus implicated in the common cold
and thus ideally suited to infecting pulmonary tissue has been modified to
carry a working copy of the CFTR gene,20 though as the additional genetic
material is not incorporated into any progeny of the target cells, repeat dosage
was necessary. Adenoviruses, however, tend to provoke a strong immune
response and, after multiple doses, this response can become increasingly
severe. Even modification of the virus to minimise this effect is not always
successful, and an adenovirus-based delivery method has led to the death
of one patient suffering from ornithine transcarbamylase deficiency during
Phase I clinical trials, due to an inflammatory reaction to the vector.56
1.3.2 Non-Viral Vectors
In addition to problems of pathology and other undesirable biological effects,
it may be impractical to transduce long segments of DNA using viral vectors.
As many human genes are indeed very large, either truncated versions
must be engineered that maintain the full functionality of the original or,
alternatively, non-viral vectors capable of transfecting large sections of DNA
must be explored.20
Without the integrase enzymes present during retroviral transduction, non-
viral vectors are not capable of incorporating a significant proportion of their
load into the target cells’ chromosomes. While this may be of some concern
when treating the most prolific cells, in the case of CF or DMD it is not
an issue; the target cells in these conditions replicate slowly, if at all, and
passing the additional genetic information along to their progeny is therefore
of little importance. Maintaining the foreign DNA as distinct episomes
also carries the advantage of avoiding disruption of viable genetic material,
hopefully reducing the incidence of gene therapy induced cancers. Aside
from these common advantages, the range of available non-viral methods
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is as broad and varied as that of viral vectors. The common factor linking
these approaches is the presence of cationic groups in the complexing agent.
The electrostatic interaction between the cationic moiety and the anionic
phosphate backbone of the DNA helix serves to provide a strong attraction,
binding the DNA to the vector and allowing the transport of the genetic
material to be facilitated by the binding agent’s specific physicochemical
properties. In addition, the resulting charge-neutralisation causes collapse
and compaction of the oligonucleotide which further assists in the process of
cell membrane trafficking.35
Lipoplexes
As biological molecules present naturally in a wide array of forms, lipids,
with or without significant synthetic modification, present themselves as
candidates upon which further DNA-binding and delivery agents can be
based. Lipids typically self-assemble due to their predominantly hydrophobic
nature, and the cationic head group present naturally in many fatty acids or
phospholipids will interact favourably with DNA. Such groups can also be
introduced synthetically. Cationic lipid-DNA complexes, or lipoplexes, lack
the immunogenicity and possible pathogenicity of viral vectors. In addition
they are biodegradable and relatively easy to prepare. Lipoplexes also
promise a degree of tuneability through covalent modification or blending
of different lipids, with the charge, structure of the hydrophobic portion,
and spacing between the charged and hydrophobic moieties all playing a
part in DNA-binding and transfection capacity.62 After complexation, the
resulting DNA-containing liposomes interact electrostatically with anionic
cell-surface glycoproteins and then fuse with the phospholipid membrane,
enabling passage of the lipoplex into the interior of the cell.35,63 Uptake of
intravenously injected lipoplexes is rapid; within five minutes of injection
nearly two-thirds of the total concentration of a DNA-lipid complex could
be found in the liver and lungs alone, with less than 3 % remaining in the
blood. This can be contrasted with free DNA, of which 36 % remained
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after five minutes, before rapidly degrading.59 Once inside the cell, the
packaging afforded by the charge-neutralisation effect of the cationic lipids
further facilitates transport of the DNA through the cytoplasm. The interior
of the cell is not homogeneous, and it is thought that cytoskeletal elements
function in a manner akin to molecular sieves, inhibiting the diffusion of large
molecules. Highly-compacted nucleotides will, therefore, be able to diffuse
through the cell more rapidly.35
While lipoplexes typically do not exhibit the negative immunological effects
associated with viral vectors, at higher concentrations the cationic lipids used
can exhibit cytotoxicity, leading to cell death.63 Increasing the concentration
of the cationic lipids does, however, improve the degree of transfection63
presumably in part due to improved packaging of the DNA and perhaps
in part due to the proton-sponge effect.64 Upon entry into the cell, the DNA-
lipoplex will, for some time, exist within an endocytic vesicle or endosome,
a bubble of cell membrane within which the cell can partition and control
the chemical environment and diffusion of foreign substances. Cells will
then acidify these vesicles, and exit from the endosome is essential if the
genetic material is to avoid degradation, and move through the cytoplasm in
order to gain access to the nucleus. The acidification of the endosome can
be manipulated in order to facilitate this exit; protonatable sites in the vector
will act to buffer the endosomal environment, forcing the cell to introduce
ever-increasing concentrations of ionic solutes. The resulting osmotic swelling
eventually leads to the bursting of the endosome and discharge of its contents
into the cytoplasm. This process can be aided by the addition of promoters
such as chloroquine, however, as with the cationic lipids themselves, higher
concentrations of chloroquine will lead to cytotoxicity and cell death.65 The
efficacy of chloroquine in aiding transfection has been taken to support the
endocytosis-based model for lipoplex entry.66 It has also been demonstrated
that in some cases lipoplexes or nucleotides are able to pass through the
endosome or cell membrane using a “flip-flop” mechanism, in which lipids
in the lipoplex are exchanged with those in the membrane.67,68
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Trials involving lipoplex-based aerosols monitored the presence of CFTR
DNA and mRNA in nasal epithelia, and quantified the expression of the
gene by measuring the conductance and absorbance of chloride and sodium
ions respectively. Levels of expression were transient, and low, but were
comparable to those observed when investigating adenovirus based vectors.
Unlike the adenovirus, however, the lipoplex aerosol did not trigger an
immune response.56
Polyplexes
Cationic polymeric molecules, both biologically-derived and entirely syn-
thetic, have been explored as DNA-binders. Akin to the naming logic
behind the term “lipoplexes,” these polymer-DNA complexes are commonly
known as “polyplexes.” Gene delivery was initially demonstrated in 1975,
both in vitro and in vivo, using a lysine-based polymer. In their simplest
polylysine form, molecular weights above 3000 Da are required for effective
DNA complexation. Further investigations, modifying lysine oligomers
with the addition of other peptides or non-biologically derived molecules
such as imidazole, have demonstrated improved DNA-binding and reduced
cytotoxicity.35
As with lipoplexes, it is the cationic nature of the protonated amine moieties
on lysine that enables binding of the anionic DNA phosphate backbone.
Accordingly, high-molecular weight, highly-branched polyethylenimine
(PEI - Figure 12) has demonstrated considerable transfection efficiency.35
Again, the structure of this polymer-based vector has been modified in
order to improve its DNA-binding capacity, and reduce its cytotoxicity -
demonstrated, in PEI, as being due to compromise of cell surface membrane
and mitochondrial membrane integrity.35,69 Derivatisation with polyethylene
glycol (PEG) known as “PEGylation,” inhibits unfavourable interactions
between the vector and blood components by creating a hydrophilic surface
on the polyplex.
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Figure 12: Portion of a branched polyethyleneimine (PEI) structure
Complex Dissociation
Contrary to initial expectations, the acetylation or addition of dextran groups
to PEI vectors has been shown to improve gene transfection capacity, in
one instance by a factor of nearly 60.70 It would be thought that the
functionalisation of otherwise protonatable nitrogen atoms would reduce
gene delivery by preventing efficient binding of DNA in the polyplex. While
it is indeed the case that reducing the potential net charge of the polymer
will reduce its affinity for DNA, this seems, to an extent, to be beneficial for
gene expression, presumably due to facilitating dissociation of the complex
after delivery into the cell. The introduction of biodegradable moieties into
the vector is a further means of reducing the strength with which the DNA
is bound, and, if these groups are carefully selected, only after entry into
the cell. A polylysine derivative, containing a number of cysteine residues
was held together in part by disulfide bonds, allowing the vector to break
down after entry to the cell.71 In PEGylated polyplexes, the polymer is
hydrolysable,allowing the vector to degrade once inside the cell.72
Charge-density
While the net cationic charge is an important factor in the tolerance of the cells
to a non-viral vector, it would appear that spreading out this charge has the
capacity to reduce cytotoxicity without compromising transfection efficiency.
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Modified lipoplexes, in which the ammonium cations were replaced with
arsonium or phosphonium groups, possessed lower charge-density due to the
larger ionic radius of As+ and P+ as compared to N+. Another alternative
that has been explored is the replacement of the ammonium group with
pyridinium, allowing the charge to be delocalised around the aromatic ring.35
The incorporation of arginine units into peptide-based polyplexes contributes
towards a reduced cytoxicity relative to lysine, due to resonance across the
guanidinium cation.6,73 Molecules in which the same net charge is more
spread out demonstrate an increased transfection efficiency i.e., reducing the
charge density while maintaining the overall charge of the molecule actually
improves transfection as well as reducing the vector’s toxicity.35 The need
for efficient gene delivery, and the clear problems with the use of viral
vectors in vitro, highlights the importance of research into novel DNA-binding
compounds.
1.3.3 DNA-binding Dendrimers
Just as highly-branched polyethyleneimine polymers demonstrate a higher
capacity for DNA binding than those based on linear PEI,35 vectors based
on dendrimers have shown a high degree of DNA-binding and gene
transfection capability. Dendritic polyamidoamine (PAMAM) has been shown
to efficiently bind DNA, and has been commercialised as an in vitro gene
transfection agent, while dendritic polylysines have been developed that
show comparable levels of transfection with reduced toxicity.74
Dendrons and dendrimers provide well-defined polymer-type properties,
allowing for control over both the degree and extent of any branching
and thus the overall molecular weight and number of surface groups.
Modification of the dendrimers’ primary and secondary structure has been
shown to affect the morphology of the resulting DNA-dendrimer complexes:
treatment of hydroxyl terminated PAMAM dendrimers with methyl iodide
results in permanently cationic dendrimers which produce more highly
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compact polyplexes,75 while PAMAM dendrimers heated to “fracture” their
spherical structure (Figure 13) have been shown to form toroid shaped
units when bound to DNA.76 These toroidal complexes have demonstrated
improved transfection ability, and have been commercialised as Superfect R©.77
Figure 13: Unmodified (top) and “fractured” (bottom) PAMAM dendrimers, showing
secondary structure (left) and primary chemical structure (right).76
A number of groups have investigated the surface modification of
otherwise nitrogen-poor dendrons.78,79 Using standard Newkome and
Fréchet syntheses,80–82 well-characterised and well understood dendrons
can be produced in high yields; simple coupling to amine-rich terminal
groups then provides a cationic surface capable of efficient binding of
DNA (Figure 14).79 Such strong binding is not typically cause for concern
in the construction of structural nanohybrids. However, in dendrimers
destined for use in gene therapy, the considerable strength with which
these multivalent polyamines form complexes with DNA has, in some cases,
been demonstrated to be detrimental to transfection, with the delivery and
expression of the packaged genes hindered by low rates of decomplexation
inside the cell. Attempts have been made to aid the dissolution of these
complexes, either by introducing hydrolysable groups into the dendrimer’s
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shell,83 or by reducing the ionic strength of the surface groups by replacing
a polycation such as spermine with a less protonatable alternative such as
N,N-di-(3-amino-propyl)-N-(methyl)amine (DAPMA).
Figure 14: G1 & G2 amide Newkome ether dendrons, with spermine-based surface
groups.84
Synthetic vector design has considered not just covalent branching, but also
the potential provided by self-assembled multivalency.85 Just as multiple
cationic lipids act cooperatively during lipoplex formation, amphiphilic
dendrimers and dendrons will, if possible, assemble into highly-charged
aggregates, further enhancing their DNA-binding ability. Steric hindrance
must be taken into account, with more linear, planar molecules often being
more able to form aggregates but perhaps losing some of their covalent
branching and multivalency in return.78 Study of a library of asymmetric
diphenylacetylene dendrons demonstrated that increased branching in the
hydrophobic heads of otherwise self-assembling molecules discouraged
formation of dimers, presumably due to the increase in steric bulk.21 The
tendency of dendritic molecules to self-assemble or to dissociate in response
to their covalent structure and external environment can be harnessed to
increase or decrease the effective multivalency of the dendrimer aggregates.
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Through careful tuning of the steric properties and the protonatability of
the component dendrons, the morphology of the resulting DNA-polyplexes
can be made pH responsive, with clear implications for controlled release or
uptake of DNA.86
Dendrons have been synthesised that self-assemble “inside-out” in the
presence of DNA, with their branched, cationic head groups facing toward
the centre of the polyplex while their tails face outwards.15 In such structures,
the DNA acts as the core of this non-covalently formed hybrid, while the
tails of the component dendrons, now the surface of the complex, can be
functionalised with tissue targeting groups or, potentially, functionalities
designed to promote interaction with other nanoscale structures (Figure 15).
Figure 15: Non-covalent nanohybrid, consisting of plasmid DNA, asymmetrical
PAMAM dendrons, PEG “tails” and cell-surface protein targeting ligands.15
1.3.4 Carbon Nanotubes as Vectors, and as Nanoscale Building Blocks
Modifying the core of such DNA binding dendrons and dendrimers to
promote their supramolecular interaction with carbon nanotubes could
provide an interesting means of facilitating DNA-CNT binding without
significant divergence from established synthetic methods, nor any need for
covalent modification of the nanotubes.
Previously, DNA-CNT hybrids have relied on covalent modification in order
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to produce functionalised carbon nanotubes (f-CNTs). The addition of,
for example, amine groups both solubilises the nanotubes and provides a
mechanism for non-covalent interaction with DNA; at biological pH the
amines are largely protonated and, as in lipo- and polyplexes, the resulting
cations interact favourably with DNA (Figure 16).87
Figure 16: Ammonium functionalised CNT (left) and an f-CNT complexed with DNA
(right). These f-CNT-DNA complexes have demonstrated effective transfection of
DNA into cells.87,88
While carbon nanotubes are not, as such, toxic, when introduced into murine
lung tissue in vivo CNTs above 20 µm in length have demonstrated “asbestos-
like” properties, leading to inflammation and scarring.89 It may be desirable,
therefore, to restrict the selection of carbon nanotubes used in gene delivery
to those below this length limit, especially if they are to be used to treat
pulmonary tissue.
Evidence suggests that, unlike most other non-viral vectors, the mechanism
of delivery does not proceed via endocytosis.35 The rigidity and length of
the nanotubes make encapsulation within an endosome implausible. In
addition, CNT-based vectors have been shown to enter the cell even after
treatment of the cells with sodium azide or 2,4-dinitrophenol, both of which
inhibit endocytosis and any other active, energy-dependent route of uptake.
It had been hypothesised that carbon nanotubes are able to pass directly
through the cell membrane without causing sufficient damage to result in
cell death.88 Molecular modelling suggests that functionalised nanotubes first
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orient themselves parallel to the cell surface, lying along the membrane. Lipid
flipping then allows the nanotube to rotate through ninety degrees, leaving
it perpendicular to, and transecting, the cell membrane.90 A reversal of the
procedure should then leave the nanotube either outside or inside the cell.
Analysis by transmission electron microscopy has shown that once f-CNTs
have entered the cell, they tend to become localised in the nucleus.88
As stated above, covalent modification of the carbon nanotube surface
may have detrimental effects on the properties of the bulk material. It
may, therefore, be desirable to explore routes that allow functionalisation
of the carbon nanotubes by non-covalent means, facilitating strong CNT-
DNA binding without the need for harsh treatment of the nanotubes. The
creation of a three-component nanohybrid, in which an additional molecule
is capable of strong non-covalent binding to both carbon nanotubes and DNA
could satisfy these aims. Molecules capable of non-covalent interaction with
both DNA and carbon nanotubes could be thought of as a loosely attached
bridging unit, or a nanoscale glue.
Hirsch et al. have demonstrated that their perylene bisimide (PBI) dendrimers
(Figure 17) are capable of adsorption onto the surface of single-walled carbon
nanotubes, disrupting the nanotube bundles and effectively solubilising
the carbon nanotubes in pH 7.0 buffered aqueous solutions.36 Several
dendrimers were investigated, with asymmetric dendrimers providing the
best solubilising effect. It was theorised that this was due to a greater degree
self-assembled multivalency, with the formation of the dendrons into micelle
type structures encouraging the carbon nanotubes to dissolve.91
A number of molecules based on the pyrene moiety have also been shown to
solubilise carbon nanotubes via pi-pi interactions between the aromatic unit
core and the CNTs’ extended aromatic systems.39,92,93
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Figure 17: Symmetric, bolaamphiphilic (top) and asymmetric, amphiphilic (bottom)
first generation perylene bisimide dendrimers, capable of solubilising SWCNTs.36
1.4 Aims
These dendritic perylenes and pyrenes show clear potential for function-
alisation with polyamine groups, via the type of amide coupling routes
and dendron syntheses previously demonstrated in the Smith group.94 This
approach would afford dendrons or dendrimers capable of supramolecular
interaction with both DNA and carbon nanotubes, providing an interesting
means of facilitating DNA-CNT binding without significant divergence from
established synthetic methods, nor any need for covalent modification of
the nanotubes. This will open up a fully non-covalent route for the
creation of DNA-CNT nanohybrid complexes. It should then be possible
to investigate the physical behaviour of these complexes. Ultimately, such
an interaction may be used to produce non-endocytic gene-delivery agents
without any need for covalent functionalisation of the carbon nanotubes.
Alternatively, programmable DNA-DNA interactions could be used to control
the complexation of DNA PBI CNT nanohybrids into even larger units in
solution, or existing “DNA origami” techniques could be used to produce
complex scaffolds onto which pristine nanotubes could be patterned while
maintaining their desirable physical and electronic properties.
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The use of dendritic molecules suggests great potential for fine-tuning the
degree of binding of these complexes; in contrast to the poorly defined DNA
binding sites on f-CNTs it should be possible to control the number and
binding strength of sites on the non-covalently functionalised nanotubes by
modifying the degree of aggregation of the dendritic molecules, as well as the
number of surface amine groups.
The formation of micellar structures by aromatic dendrimers has been
documented in previous studies, and has been implicated in enhanced carbon
nanotube binding due to an alternative dendrimer-CNT binding mode.36
The addition of surface polyamine groups may affect the degree of micelle
formation, as might the binding of DNA to these micelles, and consequently
increase or decrease the degree to which the micelles are capable of binding
CNTs.
Figure 18: G2 perylene bisimide dendrimer, with DAPMA based surface groups.
Investigating the synthetic modification of Hirsch’s perylene bisimide
dendrimers, as well as their binding to both carbon nanotubes and DNA,
will be of significant interest (Figure 18). Out of consideration for possible
gene-therapeutic applications, and in the interest of comparison with similar
dendritic molecules synthesised in the Smith group, the surface groups of
both the perylene bisimide dendrimers and the perylene dendrons will be
terminated with DAPMA rather than spermine, as discussed above. This
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approach is also synthetically beneficial, with the absence of secondary
amines in DAPMA (in contrast to the two present in the spermine molecule)
reducing the complexity of the protection steps required in the synthesis.
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2 Synthesis
2.1 G1 DAPMA-Terminated Perylene Bisimide Newkome
Dendrimers
Hirsch’s perylene bisimide dendrimers were chosen for modification due to
their demonstrated affinity for single-walled carbon nanotubes. Synthesis of
these molecules was largely carried out as reported in the literature, albeit
with some procedural modifications deemed necessary due to unavailability
of the required reagents. The surface groups were then modified to bear
multiple polyamine groups via an amide-coupling route.
Scheme 1: Synthesis of “Behera’s amine,” 2, also showing the undesirable cyclic
product.
Synthesis of the dendritic branching unit follows the method described for
the preparation of “Behera’s amine” by Newkome, Behera et al. in 1991.80
The nitro functionalised dendron was prepared by Michael addition of tert-
butyl acrylate to nitromethane, with Triton B, a common surfactant, acting
as a base. The reaction proceeded in good yield, with the product isolated
via recrystallisation from ethanol. During hydrogenation of this dendron to
produce 2, some problems were encountered, with significant percentages of
a cyclic impurity produced (Scheme 1). After purification by chromatography,
further quantities of this impurity seemed to form during storage.
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Scheme 2: Synthesis of a DAPMA-terminated G1 dendrimer, 8, based on Hirsch’s
PBIs.
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The synthesis was modified to take into account further work reported by
Newkome and Weis in 1996. The temperature at which hydrogenation was
carried out was lowered from 60 ◦C to below 55 ◦C. In addition, their
recommendation that in vacuo solvent removal be carried out below 50 ◦C was
taken into account.81 Following these amendments, the procedure produced
the amine in high yield and with minimal impurities, with no need for
purification (Figure 19). The product was then stored in a dry, nitrogen filled
flask (in order to avoid water condensing inside the flask upon cooling) at ca.
-18 ◦C in order to minimise any risk of cyclisation during storage.
Figure 19: 1H NMR spectra of “Behera’s amine” showing significant impurities (top)
and the pure product produced by hydrogenation at lower temperatures (bottom).
Further difficulty was encountered during the addition of the 6-carbon
spacing unit (2, Scheme 2); introduced by Hirsch et al. in order to distance
the aromatic perylene unit from the bulky side groups and so facilitate
aggregation of the dendrimers, and carbon nanotube binding.95 The reported
synthesis required hydroxybenzotriazole (HOBt), a commonly used peptide
coupling reagent, and dicyclohexylcarbodiimide (DCC) (Scheme 3).96,97
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Scheme 3: Mechanism of amide coupling facilitated by HOBT and DCC.
HOBt was unavailable at the time due to reclassification as an explosive
material, with restrictions on transportation and storage Accordingly, a
method based on 2-propanephosphonic acid anhydride (T3P) was used in
its place (Scheme 4). While amide-coupling using T3P can be more sensitive
to moisture than HOBt-based procedures, the by-products of the reaction are
water-soluble. T3P was readily available as a solution in ethyl acetate, and
several test reactions were carried out (Table 1).
Reagents Time Temperature Yield
HOBt, DCC, DMAP95 14d r.t. 92%
T3P, Et3N 4d r.t. 10%
T3P, DIPEA 1d r.t. 19%
T3P, DIPEA 5d 40 ◦C 17%
T3P, DIPEA 16d r.t. 21%
Table 1: Yields of amide coupling reactions between Behera’s amine and Z-caproic
acid, comparing HOBt with various T3P conditions.
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Scheme 4: Mechanism of amide coupling facilitated by T3P.
Unfortunately, using T3P gave poor yields. The long reaction times, even
for the reported HOBt route, are due to the sterically hindered, neopentyl
nature of the dendron. It was unclear if low yields with T3P were a result of
poorly optimised methodology and production of side-products, or if they
were also a consequence of steric hindrance, with the reaction requiring
more time to reach completion. A change of amide-coupling reagent from
T3P to tetramethyl-O-(benzotriazol-1-yl)uronium tetrafluoroborate (TBTU),
which is known to assist sterically hindered amide couplings, provided
vastly improved yields.98 Structurally and mechanistically, TBTU bears more
resemblance to HOBt than to T3P (Scheme 5).
The yields obtained, while a significant improvement over the T3P-based
methodology, were still lower than those reported using HOBt (Table 2).
However, given the unavailability of the latter reagent, TBTU was used for
all further amide couplings.
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Scheme 5: Mechanism of amide coupling facilitated by TBTU, showing no need for
additional coupling reagents such as DCC or DMAP.99
Reagents Time Temperature Yield
HOBt, DCC, DMAP95 14d r.t. 92%
T3P, DIPEA 16d r.t. 21%
TBTU, DIPEA 12d r.t. 70%
Table 2: Yields of amide coupling reactions between Behera’s amine and Z-caproic
acid.
The branched dendrons, now complete with spacer units, were then coupled
to a perylene core via Lewis acid mediated imide formation (Scheme 6).
Using molten imidazole as a solvent provides both a basic environment
and efficient leaving group; the reaction was, therefore, carried out at 110
◦C. Zinc acetate, present in sub-stoichiometric quantities, acts as a Lewis
acid catalyst.95,100 Purification was acheived by column chromatography,
with the now strongly coloured products clearly visible to the naked eye.
Accordingly, identification of perylene containing fractions did not require
further visualization techniques. Both mono- and disubstituted products
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were obtained and were clearly identifiable by NMR.
Scheme 6: Mechanism of imidazole and Lewis acid mediated cyclic imide formation.
After deprotection of the disubstituted tert-butoxycarbonyl (Boc) protected
G1 dendrimer with formic acid, NMR and mass spectroscopy both indicated
that the desired compound had been isolated. Fluorescence spectra were
measured, in pH 7.0 buffer, at two concentrations. Upon aggregation, PBI
dendrimers show a shift in their absorption and fluorescence wavelengths.
This typically leads to two distinct maxima, and the proportions of
aggregated and non-aggregated perylenes can be monitored by observing
the relative absorbance or fluorescence of these frequencies. Accordingly,
the absorption and fluorescence spectra are concentration dependent.101 The
fluorescence spectra measured corresponded to concentrations roughly one
order of magnitude lower than expected. This may be attributable to the
strongly hygroscopic nature of the amphiphilic dendrimers, resulting in the
absorption of a significant mass of water from the air during handling.
Indeed, when the remaining product was reweighed some time after the
deprotection had been carried out, the mass was found to be was roughly
ten times the expected value. When synthesising further samples, great care
was taken to remove all solvent under high-vacuum and to keep the resulting
dry film under argon, following which all fluorescence spectra obtained
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correlated closely with those reported in the literature.
Large quantities of Boc-protected N,N-di-(3-aminopropyl)-N-(methyl)amine
(Boc-DAPMA) were available, having been previously synthesised by others,
from DAPMA and di-(tert-butyldicarbonate) in tetrahydrofuran (THF), and
purified by extraction from dichloromethane (DCM) using 10 % citrate.
Initial attempts at amide-coupling of Boc-DAPMA to the carboxylic acid
terminated PBI dendrimer, 6, were unsuccessful, producing an insoluble
pink powder that could not be characterised. Molecular sieves were
employed in an attempt to remove excess water and so assist in driving
the reversible coupling reaction to completion, however this merely resulted
in staining and crumbling of the sieves, degradation of which may account
for the uncharacterisable, insoluble powder obtained from the reaction. A
further attempt to produce the desired product, this time omitting the
use of molecular sieves, and using the well-defined, pure and dry 6 that
had been kept under argon produced a deep-red solution that was then
purified by size-exclusion chromatography over Bio-Beads R© to give the hexa-
substituted amide. However, further purification was required: while the
chromatography procedure used was successful in separating the desired
product from less substituted side products, the resulting solution was
contaminated with large quantities of an aromatic compound.
While a repeat of the above chromatography procedure did not appear to
remove the remainder of this undesirable aromatic residue, eluting over
Sephadex R© with methanol provided the amide free of any impurity readily
observable by 1H NMR or UV/Vis spectroscopy (Figure 20). As may
be expected when working with compounds so prone to intermolecular
association, significant broadening of chemical shift peaks was observed in
the 1H NMR spectrum of this compound. In addition, and presumably due
to the same factors, no 13C NMR spectrum could be obtained, even after
decreasing the concentration of the sample in order to reduce the degree of
pi-pi stacking between perylene moieties, and considerably lengthening the
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Figure 20: UV/Vis absorbance spectra of G1-PBI-BocDAPMA, 7, contaminated with
large quantities of an aromatic impurity (light blue), and after purification over
Sephadex R© (black).
duration of the NMR experiment.
The butoxycarbonyl protecting groups were removed by stirring 7 in
methanol acidified with gaseous HCl, providing the deprotected DAPMA-
terminated dendrimer as its hydrochloride salt. Once again, significant
broadening of chemical shifts in 1H NMR spectra of the compound made
accurate assignment of specific protons difficult, with the relative integration
of some peaks difficult to determine accurately. 13C NMR produced no
observable peaks across a wide range of concentrations. Mass spectrometry,
however, clearly showed the desired product as 2+, 3+, 4+ and 5+ ions.
No significant impurities appeared to be visible by 1H NMR, nor were any
chromophore bearing impurities observed in the UV/Vis spectrum of the
compound. Accordingly, no further purification was carried out.
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2.2 G2 DAPMA-Terminated Perylene Bisimide Newkome
Dendrimers
The second-generation, DAPMA-terminated dendrimer was synthesised in
order to investigate the effects of the degree of multivalency and increased
steric bulk upon the PBI dendrimers’ affinity for DNA.
Scheme 7: Synthesis of DAPMA-terminated G2 dendrimers based on Hirsch’s PBIs -
initial steps
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Scheme 8: Synthesis of DAPMA-terminated G2 dendrimers based on Hirsch’s PBIs -
final steps
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The G1 carboxyl-terminated dendrimer 6, synthesised as described above,
was used as the starting point for the synthesis. A convergent approach was
used, coupling “Behera’s amine” to the periphery of the dendrimer using
a TBTU-based coupling methodology. The resulting G2 dendrimer, 9, a tert-
butyl ester, was purified by column chromatography in ethyl acetate (EtOAc),
giving the desired product in reasonable yield. The tert-butyl protecting
groups were then removed in formic acid in quantitative yield to give the
G2 carboxyl-terminated dendrimer, 10, ready to be coupled to Boc-protected
DAPMA (Schemes 7 and 8).
The coupling of Boc-DAPMA to the G2 carboxyl-terminated dendrimer was
largely carried out as described above in the synthesis of the G1 Boc-DAPMA
derivative, albeit with the reaction time extended in order to encourage
the complete substitution of reaction of the eighteen peripheral groups (in
contrast to the G1 dendrimer’s six peripheral amides). However, while the
first generation dendrimer was readily soluble in a 1:1 mixture of DCM
and pyridine, this solvent system failed to solubilise the G2 dendrimer.
While the reagent in question was fully soluble in MeOH, alcohols are
unsuitable solvents for this reaction due to the potential formation of
esters. After screening a range of solvents, a 3:2 mixture of pyridine and
dimethyl sulfoxide (DMSO) was deemed suitable. As in the synthesis of
the G1 dendrimer, the product was isolated as a red solid which was
then separated by size-exclusion chromatography over Bio-Beads R©, eluting
with DCM. Again, as with the Boc-DAPMA coupling to the first-generation
dendrimer, which was carried out simultaneously, the earlier fractions (those
containing the larger molecules, expected to be the substituted product)
were contaminated with a UV chromophore containing impurity. Size-
exclusion chromatography, eluting over Sephadex R© with methanol, once
again provided the desired product free of observable impurities, along with
what appeared to be the incompletely substituted amide, isolated as a second
fraction (Figure 21).
Analysis of the resulting fractions by 1H & 13C NMR failed to provide clear
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Figure 21: UV/Vis absorbance spectra of 11 after purification over Sephadex R©
showing the first (black) and fifth (green) fractions, with the latter still clearly
containing a proportion of the aromatic impurity.
and conclusive evidence regarding the degree of substitution of the products.
Formation of aggregates in solution due to stacking of the perylene cores
leads to significant broadening of peaks, leading to difficulty in ascertaining
the accurate chemical shift and integration of the signals. This broadening
is particularly prevelant for those peaks relating to the carbon or hydrogen
nuclei in the perylene core and, accordingly, the relative magnitude of the Boc
and perylene integrals is difficult to calculate precisely.
Analysis of these samples by mass spectrometry also proved challenging;
neither electrospray ionisation (ESI) nor matrix-assisted laser desorption
ionisation (MALDI) provided spectra showing the molecular ion peak. Again,
this was presumed to be related to the formation of aggregates by the Boc-
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protected dendrimers (as some difficulty had been noted obtaining spectra
for the G1 analogue, 7) as well as being in part due to the considerable mass
of these compounds, with the fully substituted dendrimer, 11, having a mass
of 6545 Da.
UV/Visible spectrophotometry, in addition to confirming the removal of
any impurities possessing UV chromophores, showed a significant difference
between the two fractions when prepared as equimolar solutions in methanol
(Figure 22). The proportion of peak heights in perylene bisimides has been
shown to correlate with the degree of stacking of the compounds: the peak
around 480 nm correlates with pi-pi stacked perylene units, while the peak
around 520 nm correlates with unstacked perylenes. Accordingly, the strong
480 nm peak in the spectrum of the second fraction is indicative of a reduction
in stacking. In previously published work, a G2 octadecacarboxylic acid-
terminated perylene bisimide exhibited less stacking than its G1 analogue
due, presumably, to the greater steric hindrance provided by the higher
degree of branching, as well as electrostratic repulsion due to greater charge.
The apparent difference in stacking between the two solutions could,
therefore, be the result of electrostatic repulsion of charged groups, steric
clash, or differences in molarity. Should one or other fraction be incompletely
substituted, the change would affect these three properties in the following
ways:
Molarity An incompletely substituted fraction would have a lower Mw than
predicted and, accordingly, a solution of equal w/v concentration would be of
lower molarity than expected (and of lower molarity than a solution prepared
containing the fully substituted product). This solution would, therefore,
demonstrate reduced stacking.
Steric Clash It would be expected that an incompletely substituted product
would possess less steric bulk, a barrier to stacking. Accordingly, like its
first generation counterpart, a greater proportion of the compound would be
present in the stacked form.
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Figure 22: UV/Vis spectra of the first (red) and second (orange) fractions of 11
obtained by size-exclusion chromatography, after removal of solvent in vacuo and
preparation of solutions of equal w/v. N.B. In the absence of any other data, when
preparing solutions it was assumed that both fractions contained only pure, fully-
substituted second generation Boc-DAPMA substituted perylene bisimide. Should
this not be the case, the solutions will not be equimolar.
Charge The presence of charged groups should, through electrostatic
repulsion, decrease the stacking of the perylene units. Both the starting
material and the desired product contain chargeable moieties; in the case
of the starting material some of the carboxylic acid groups will deprotonate
in solution, affording anionic dendrimers, while the desired product carries
protonatable secondary and tertiary amines some of which should, in
methanol acquire protons and impart a cationic character to the molecule.
The situation is complicated by the possibility that one or both fractions
contain partially but incompletely substituted material, in which case the
dendrimers may possess a net positive or negative charge or no charge at
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all, depending on whether each molecule is predominantly cationic, anionic
or zwitterionic.
A variable pH experiment was designed in order to test the hypothesis that
one of the fractions may consist of the incompletely substituted G2 dendrimer.
By modifying the pH of the solution and protonating or deprotonating any
amine or carboxyl moieties, the degree of stacking of the dendrimers, and
thus their UV/Vis spectrum, should be changed due to the resulting increase
or reduction in charge. As a significant reduction of the solution pH could
lead to removal of the Boc protecting groups and thus alteration of the
dendrimers’ stacking properties through covalent modification, the pH was
instead raised by the addition of triethylamine to the solutions. Triethylamine
was chosen both due to having a sufficiently high pKa (10.75 in water) to
deprotonate both acidic carboxyl groups and protonated Boc-DAPMA, and
the presumed lack of any other obvious interactions with the solute; cf.
pyridine which, in addition to possessing a lower pKa, could be thought to
affect aggregation of the dendrimers through pi-pi stacking interactions with
their perylene cores.
In both cases, addition of base increases the stacking of the dendrimers. These
experiments seem to indicate that neither fraction contains pure starting
material: the neutral or negatively charged carboxylic acid terminated
dendrimer should stack less or the same amount upon the addition of base,
depending on the initial degree of deprotonation. However, in both cases
an increase in pH appears to increase the proportion of stacked material,
suggesting a decrease in the overall charge of each molecule. This would be
consistent with deprotonation of cationic amine terminated dendrimers. As
the appearance of these fractions differs so markedly by eye and by UV/Vis
spectroscopy, it seems reasonable to suggest that, while both could contain
protonatable amines, the first fraction is more fully substituted than the other.
Upon deprotection in acidified methanol, the first fraction behaved similarly
to the G1 counterpart, with the deep-red solution turning slightly cloudy.
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After removal of the solvent, and addition of neutral methanol, the product
dissolved to give a red solution, albeit with an insoluble red film remaining
undissolved.
Deprotection of the second fraction provided further information on the pH
dependence of the material: upon acidification, the orange solution turned
red, roughly corresponding to a relative decrease of the 523 nm absorbance
and indicating stacking of the perylenes. This would suggest that significant
protonation was leading to an overall decrease in charge, indicating the
presence of acidic groups on the dendrimer. After stirring, a pale peach
coloured solution was produced in addition to a considerable quantity of
black solid. After separation, it was demonstrated that this black material
would not dissolve in acidified methanol but dissolved in neutral methanol
to give a red solution.
It would appear that both fractions contained a mixture of variously
substituted Boc-DAPMA terminated dendrimers, with the first fraction
consisting primarily of at least one more fully substituted product.
This would also be consistent with the mechanism of size-exclusion
chromatography, after which it would be expected that the more fully
substituted, and thus larger, compounds would be the first to pass through
the column. The soluble and insoluble portions of the first fraction were
separated via glass pipette, with the soluble portion then being characterised
as much as was possible given the low mass recovered (ca. 0.004 g).
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3 Investigations
3.1 DNA Binding Capability of G1 DAPMA-Terminated
Perylene Bisimide
The N/P charge ratio describes, on average, the number of nitrogen cations
required to bind each phosphate anion. In contrast to a simple ratio of
molecular concentrations, the charge ratio provides a measure of binding
efficiency that is directly comparable between binders, irrespective of the
number of protonatable nitrogen atoms per molecule. The use of the charge
ratio as a measurement also avoids any problems associated with calculating
the molecular weight of the DNA oligo- or polynucleotides used in any
assay; the calf-thymus DNA used in many binding assays tends to be very
polydisperse and calculating the number of nucleotide bases and, accordingly,
the number of phosphate units, present in the sample is a considerably easier
undertaking than determining the average length of each “DNA molecule”.
For these calculations, the average “molecular weight” of the nucleotide base
pair residues was taken to be 660 Da.102
Typically, the association of cationic molecules with DNA is measured by
indirect means. Binding to the phosphate backbone is not accompanied by
any quantifiable change in the NMR, UV/Vis, or fluorescence spectra of the
DNA and, accordingly, other means must be used to measure the magnitude
of any ionic interactions.
One frequently used method, sensitive to small changes and providing
data comparable between similar DNA-binders is the ethidium bromide
fluorescence assay.84 Ethidium bromide (EthBr) is a fluorescent dye,
commonly used as a DNA stain.104 Upon intercalating between DNA base
pairs, the fluorescence of EthBr increases dramatically. While in aqueous
solution, fluorescence is quenched by proton exchange with the solvent -
however in the solvent free, hydrophobic environment between the base
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Figure 23: Diagram of double-stranded DNA, showing nucleotide bases (green,
purple, blue and red) deoxyribose sugars (yellow) and anionic phosphate groups.103
pairs, EthBr fluoresces with around 20 to 100 times its quenched intensity,
depending on the excitation wavelength chosen.105,106
While the intercalation of ethidium bromide distorts double-stranded DNA
by causing unwinding of the double helix,107 intercalation of drugs or
other molecules,108 or binding of cationic species to the phosphate backbone
displace the bound EthBr, forcing it into solution.84 The degree of binding of
the cationic species can, therefore, be measured by monitoring the reduction
in fluorescence of the ethidium bromide as it is quenched by the solvent.
In many cases, including previous studies by the Smith group, the excitation
of ethidium bromide has been achieved using light of or around 540 nm.109
While this direct excitement of the ethidium cation’s chromophore was
adequate and appropriate in these experiments, when investigating PBIs the
fluorescence of the perylene moiety overlaps significantly at the observed
fluorescence wavelengths (around 595 nm) when excited by light at 540 nm.
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Figure 24: Comparison of DAPMA-terminated G1 perylene dendrimer emission,
exciting at 260 nm , 280 nm , and 540 nm N. Peaks below 570 nm are due to
scattering of the excitation wavelength, or its overtones. In the region to be studied
(around 595 nm) note the strong perylene emission when exciting at 540 nm, and the
minimal emission when exciting at 260 nm or 280 nm.
Published work by Blagbrough and Geall100 suggests an alternative
range of excitation wavelengths around 260 nm. Their investigations
show that excitement in this region will produce results comparable to
those obtained using excitation at a higher wavelength, with equivalent
percentage reductions in fluorescence upon addition of their cationic binder.
Furthermore, the excitement of ethidium bromide at these lower wavelengths
contains both direct and indirect components due to energy transfer from
DNA, which also possesses a chromophore in this region. Upon displacement
from the DNA, this additional excitation pathway is no longer available. This
method results in a much greater absolute reduction in fluorescence upon
displacement and, accordingly, a more sensitive assay than when directly
exciting EthBr using higher wavelengths.
Preliminary investigations suggested that excitation at 280 nm, rather than
at 260 nm, provided both strong initial fluorescence of the EthBr, and
minimal fluorescence of the perylene moiety at the observed emission
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wavelengths (Figures 24 and 25).
Figure 25: Comparison of ethidium bromide excitation, in the presence of DNA,
exciting at 260 nm , 280 nm , and 540 nm N, and demonstrating the increased
fluorescence emission intensity when using lower excitation wavelengths.
Initial investigation, exciting at 280 nm and titrating a 10 µM solution of the
DAPMA-terminated G1 perylene dendrimer reached the apparent baseline
after the addition of just 20 µl of perylene solution, equivalent to an overall
concentration of 0.1 µM (Figure 26).
In order to study the concentration range representing the greatest change
in ethidium bromide fluorescence, and to avoid the perylene fluorescence
that was observed to impinge on the spectrum at higher concentrations, the
titration was then repeated using a 1 µM solution of the perylene dendrimer,
producing a curve from which C50 and CE50 values could be calculated
(Figure 27). The C50 indicates the concentration of DNA binder required to
cause a 50% reduction in fluorescence, while the CE50 represents the charge
excess at this concentration, defined as the concentration of cations or the
nominal positive charge present divided by the nominal negative charge, in
this case the concentration of phosphate anions.102 The data for each titration
can be averaged to produce a single mean curve, and the CE50 then noted for
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Figure 26: Titration of a 10 µM DAPMA-terminated G1 perylene dendrimer solution
into a solution of 8 µM DNA with 5.18 µM EthBr. Note the initial rapid drop
in fluorescence as the majority of the ethidium bromide is displaced from its
intercalation sites, followed by the gradual rise as the concentration of perylene
increased and its fluorescence begins to impinge on the region under observation.
Samples were excited at 280 nm and emission observed at 595 nm.
this average. A separate CE50 value for each titration was calculated, and an
average calculated from these figures (Table 3).
C50 ( µM) CE50
0.070 0.10
0.032 0.05
0.023 0.03
0.058 0.09
0.049 0.07
0.046 0.07
Mean 0.046 0.07
Table 3: C50 and CE50 values calculated from six ethidium bromide exclusion assays,
in each case titrating 1 µM 8. One further titration was discarded due to significant
errors.
The particularly low CE50 value calculated for this dendrimer suggests either
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Figure 27: Titration of a 1 µM DAPMA-terminated G1 perylene dendrimer solution
into a solution of 8 µM DNA with 5.18 µM EthBr. Note the region between N/P =
0, and N/P = 0.22 (340 µl perylene solution added, total concentration = 0.15 µM)
where additional perylene displaces increasing quantities of ethidium bromide and
reduces the overall fluorescence of the sample. The CE50 corresponds to N/P at 50
% of the maximum fluorescence emission.
a particularly strong DNA binding ability, or an artifact of the indirect method
used to quantify the binding interaction.
3.2 Intercalation of PBIs into dsDNA
In the case of a simple polyamine such as DAPMA, spermine, or simple
dendritic molecules bearing those moieties such as those used in previous
studies by Smith et al. (Figure 28), the only relevant supramolecular
interactions present in solution are the intercalation of EthBr into DNA, and
the ionic interaction between the phosphate backbone of the DNA and the
cationic protonated nitrogens of the polyamine. However, the structure of
the dendrimers under investigation suggests a further possible interaction;
previous work by Kerwin, Federoff et al. has investigated the interaction of
perylene bisimides’ aromatic cores with various DNA polynucleotides.110,111
It is conceivable that intercalation of the perylenes into the DNA double-
helix would displace EthBr upon binding, adding a further, non-ionic binding
52
mode observable by the ethidium bromide assay.
Figure 28: Spermine (top left), spermine dendron (bottom left),79 DAPMA (bottom
right)112 and DAPMA dendron (top right).113
Kerwin et al. measured the intercalation of their perylene bisimide
compounds by monitoring the disruption of perylene-perylene stacking.111
Upon addition of increasing concentrations of dsDNA, they observed a
change in the UV/Vis spectrum of the perylene moiety, indicating a decrease
in the proportion of stacked perylene aggregates, and an increase in the
proportion of individualised PBI units (Figure 29). Their conclusions were
supported by a lack of the observed shift when investigating a more sterically
bulky PBI, and an increased shift when titrating G-quadruplex DNA, which
possesses a more open structure and so would be thought to interact more
easily with the perylene units.
An analogous experiment was designed to determine the degree of
intercalation of the cationic dendrimers under investigation. Double-stranded
calf thymus DNA, as used in the DNA binding assays described above, was
titrated into a 1 µM solution of 8 in 0.01 M SHE buffer (Figures 30 and 31).
After normalisation, the shifts in absorbance indicate a degree of intercalation
over the concentration range studied. The absorption of the sample at 500
nm, corresponding to the stacked perylenes in solution (cf. Figure 29 and
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Figure 29: UV/Vis absorption spectra of a perylene bisimide alone, and in the
presence of excess double-stranded DNA. The change in relative absorption of the
two peaks is indicative of individualisation of the perylene units, presumably due to
intercalation into the DNA.111
30) decreases over the course of the titration, while the absorption at 538
nm, corresponding to individualised perylenes, increases. These changes
suggest intercalation of the dendrimers’ core perylene units between the
DNA nucleotide bases, being the most likely mechanism for separation of
the aromatic, pi-pi stacking perylenes. The data represented in Figure 31 span
the relative concentrations at which the DNA-binding assays were carried
out, suggesting that in those experiments a degree of intercalation would
likely have been occurring. This should contribute to the observed N:P ratio,
although without further data, namely the relative concentration at which no
more individualization of the perylene moieties occurs, it is not possible to
determine the degree of intercalation and, therefore, what percentage of the
total dendrimer-DNA interactions results from this contribution.
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Figure 30: UV/Vis absorption spectra of 8 before (black) and after (green) the
addition of double-stranded calf thymus DNA, indicating a degree of intercalation
and resulting individualisation of the perylene moities. Data not normalised to
account for UV/Vis absorption of DNA.
Figure 31: Changes in UV/Vis absorbance of 1 µM DAPMA-terminated perylene
dendrimer at 500 nm  (left axis) and 538 nm  (right axis) upon addition of calf-
thymus DNA. All solutions made using 0.01 M SHE buffer. All data normalised
according to UV/Vis absorbance of calf-thymus DNA dilutions in 0.01 M SHE buffer.
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3.3 Low CE50 as an artifact of methodology
One further interaction that could plausibly contribute to an exceptionally
low CE50 value is the possible pi-pi stacking of perylene and ethidium
moieties. Removal of free ethidium from solution by interaction with
perlyene would shift the DNA-EthBr intercalation equilibrium in favour of
dissociation, distorting the results of the displacement assay and making the
dendrimer appear to be a better DNA-binder than is in fact the case (Figure
32).
Figure 32: Representation of the interactions between perylene dendrimers, DNA,
and ethidium moieties, and the equilibria present in solution. The diagram shows
the displacement of the ethidium cation upon binding of the cationic dendrimer to
the minor groove of the DNA (top) and the further interaction between the aromatic
ethidium cation and the electron-rich perylene moiety at the core of the dendrimers
(bottom). Removal of free ethidium from solution in the lower equilibrium shifts
the upper equilibrium to the right, distorting the results of the exclusion assay and
making the dendrimer appear to be a better DNA-binder than is in fact the case.
Unlike the intercalation of the perylene core into DNA, this EthBr-perylene
interaction does not represent an additional DNA-binding mode, rather its
contribution to the CE50 is an artifact of the indirect means used to monitor
the degree of DNA binding.
No obvious means could be found to measure and quantify the pi-pi
stacking of ethidium bromide and DNA. Preliminary studies suggested that
any stacking interactions between the perylene dendrimers and EthBr did
not individualise the perylene units to a degree observable using UV/Vis
spectroscopy, nor would these interactions produce a significant change in
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the fluorescence of the ethidium bromide when combined with the perylenes
in aqueous solution.
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3.4 DNA Binding Capability of G2 DAPMA-Terminated
Perylene Bisimide
As with its G1 analogue, 8, the DNA binding strength of the G2 DAPMA
terminated perylene bisimide dendrimer, 12, was indirectly measured using
an ethidium bromide displacement assay.
Figure 33: G2 DAPMA terminated perylene bisimide dendrimer, 12, shown as its
hydrochloride salt.
Due to concerns comparable to those expressed during the investigation of
the G1 dendrimer, regarding the fluorescence emission of the perylene moiety
beginning to impinge upon the assay at higher concentrations, the assay was
carried out at a 1 µM concentration of 12. The low mass of material available
made precise determination of the concentration difficult. However, after
dissolving the available solid in 0.01 M SHE buffer, the UV/Vis absorption
of the resulting solution was compared with that of various concentrations
of 8, its G1 counterpart. It was reasoned that, broadly, the absorbance of
the perylene core would correspond to the concentration of that moiety in
solution, regardless of the generation of the dendrimer’s shell. However, as
discussed previously (Section 2.2) the maxima of the perylene absorbance are
not an accurate reflection of concentration, and their relative heights vary
depending on the degree of aggregation of the compound. A wavelength on
the edge of the perylene absorption region, at 700 nm, was found to follow the
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Beer-Lambert law, with its absorbance increasing linearly with concentration.
The concentration of the G2 solution was therefore found to approximate to
5 µM, allowing dilution to afford the desired 1 µM solution.
Expressed as a charge-excess, N/P, the concentration of protonated groups
is clearly much higher in the second generation dendrimer than in its first
generation counterpart. It was of some surprise therefore, when, upon
addition of a concentration of the G2 DAPMA-PBI comparable to the C50 of
the G1 dendrimer, the fluorescence had only diminished by around one-third.
C50 ( µM) CE50
0.090 0.40
0.120 0.54
0.097 0.43
Mean 0.102 0.46
Table 4: C50 and CE50 values calculated from three ethidium bromide displacement
assays, in each case titrating 1 µM G2-DAPMA-PBI 12.
In contrast to the mean values obtained from titrations of the G1-DAPMA-
PBI, 8, (C50 = 0.046 µM, CE50 = 0.07), the G2 dendrimer’s C50 of 0.102
µM and CE50 of 0.46 are unexpectedly low, especially considering the
expected increase in binding, observable in similar, albeit non self-assembling
systems. Apart from the inaccurate method of determining the initial solution
concentration, which might be expected to account for some but not all
of this effect, it seems plausible that the observed reduction in binding
affinity would be, at least in part, the result of the increased size of the
dendrimer. Just as Hirsch et al. demonstrated that their smaller or less
symmetrical perylene dendrimers were more able to solubilise CNTs due to
increased micelle formation, these larger dendrimers may exhibit a reduction
in their self-assembled multivalency. Both the steric bulk and increased
charge of the branching units could be expected to hinder the formation of
aggregates, preventing some of the self-assembled multivalent effect that has
been implicated in the remarkably low CE50 of the first-generation DAPMA-
terminated dendrimer (Section 3.1).
In addition to inhibiting perylene-perylene stacking, the increased bulk of
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the second generation branching unit would also be expected to hinder
intercalation of the dendrimer’s core into dsDNA. Kerwin et al. demonstrated
that larger perylene bisimides were less able to intercalate into double-
stranded DNA,111 and the increase in size from first- to second-generation
may lead to a corresponding inhibition of the expected intercalation binding
mode. Accordingly, this may account for a portion of the reduction in total
binding.
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3.5 CNT Binding Capability of G1 DAPMA-Terminated
Perylene Bisimide
The binding of carbon nanotubes by perylene-CNT pi-pi stacking is not
measured by assay. Qualitatively this interaction can be observed through
the formation of stable carbon nanotube solutions; Hirsch et al. have shown
that amphiphilic perylene dendrimers can solubilise and individualise CNTs
to a significant extent.36
Carbon nanotubes shaken or sonicated in water or in SHE buffer solution will
not separate considerably, and will rapidly clump and settle in the vial. 2 ml
of a 10 µM solution of the first-generation, DAPMA-terminated dendrimer, 8,
was sonicated with 0.09 mg of carbon nanotubes, producing a stable deep-red
solution.
Titration of CNT-perylene solutions into a perylene solution of equivalent
concentration should allow the nature of the solubilisation to be probed.
The UV/Vis spectra produced by the titration show an increased absorbance
at all wavelengths, presumably due to absorption and scattering by the
carbon nanotubes (Figure 34). At all observed wavelengths the increase in
absorption appeared to be linear with respect to concentration, following
the Beer-Lambert law and so supporting the hypothesis that the carbon
nanotubes were present in solution rather than as a suspension. At no point,
however, were the van Hove singularities characteristic of individualised
CNTs observable; these appear as jagged regions in the UV/Vis spectrum.36
This would suggest that, while solubilised, within the range of concentrations
and perylene-CNT ratios studied nanotubes were not individualised to an
observable degree, existing instead as bundles of several nanometres in
diameter.
Solutions of carbon nanotubes were prepared in 0.01 M SHE buffer using
sodium dodecylbenzenesulfonate (SDBS) as a surfactant. The UV/Vis spectra
of these solutions were measured and subtracted from those of the perylene-
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Figure 34: UV/Vis absorption of 10 µM DAPMA-terminated G1 perylene dendrimer
(green), the same perylene solution with 0.01 g L−1 single-walled carbon nanotubes
(pink), and a solution of 0.01 g L−1 single-walled carbon nanotubes in 0.7 mM SDBS
(black).
CNT titration in order to normalise the spectra with respect to the carbon
nanotubes.
Data were normalised at 500 nm and 543 nm, values representing the
absorption of light by stacked perylenes and unstacked, individualised
perylene units respectively. Upon increasing concentration of CNTs there
appeared to be a corresponding increase in the proportion of unstacked
perylenes, though to be due to the disassembly of perylene aggregates upon
interaction with the surface of the carbon nanotubes. However, the data
also appeared to show an increase in the proportion of stacked perylenes
suggesting that the increase was due to, or was within, any errors in the
normalisation (Figure 35).
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Figure 35: UV/Vis absorbance of perylene core at 500 nm  and 543 nm , with
respect to increasing carbon nanotube concentration. Data normalised to remove
carbon nanotube absorbance.
Interaction between the nanotubes and polyamine-terminated perylene
dendrimers was further probed via transmission electron microscopy. 0.0045
g L−1 carbon nanotubes were dissolved in a 10 µM solution of perylene in 0.01
M SHE buffer. Electron micrographs appeared to show carbon nanotubes,
or bundles of nanotubes, coated periodically with large, globular perylene
aggregates (Figure 36).
Micrographs were also taken of the residue from solutions of nanotubes,
perylene, and plasmid DNA, which is known to provide clearer pictures
than calf-thymus DNA when viewed using transmission electron microscopy.
Unfortunately, the images obtained did not clearly show any DNA-
dendrimer-CNT nano-hybrids; rather the structures formed appeared much
the same as those without the presence of DNA, and no DNA, bound or
free, was visible. These micrographs do not, therefore, seem to disprove
the existence of such hybrid structures, rather is is possible that DNA was
present and was bound to the CNT-perylene aggregates but was unable to be
visualised under the conditions used in this experiment (Figure 37).
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Figure 36: Transmission electron micrograph showing an 87,000 x magnification of
the residue from a solution of DAPMA-terminated perylene dendrimer and single-
walled carbon nanotubes.
Figure 37: Transmission electron micrograph showing an 87,000 x magnification of
the residue from a solution of DAPMA-terminated perylene dendrimer, SWCNTs,
and plasmid DNA.
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3.6 Effect of Carbon Nanotubes on DNA Binding Capability
of G1 DAPMA Terminated Perylene Bisimide
While it has hopefully been shown that DAPMA-terminated peryene bisimide
dendrimers are capable of interaction with both CNTs and DNA, it does
not necessarily follow that in solutions containing all three components the
desired three-component nanohybrids would be formed. Any number of
factors may discourage the formation of CNT binding to an existing DNA-PBI
polyplex, or of DNA binding to perylene-coated CNTs. Given the plausibility
of a perylene-DNA intercalation interaction forming at least part of the total
binding of DNA to the dendrimers, as discussed (Section 3.1), it might be
thought that the addition of carbon nanotubes to the DNA-PBI solutions
under investigation may inhibit such an interaction by preferentially binding
the perylene cores of the dendrimers. Alternatively, should the DNA perylene
core intercalation be particularly strong, the presence of DNA might cause
separation of the perylene units from the CNTs, leading to a reduction in
solubility and, accordingly, carbon nanotubes clumping and settling from
solution.
A simple method was devised in order to test the effect of carbon nanotubes
on the binding of 8 to DNA. An ethidium bromide displacement assay was
carried out as described above, but with the addition of 2.5 mg L−1 single
walled CNTs to the titrating mixture. This concentration was chosen as
close to the maximum carbon nanotube concentration sustainable by a 1 µM
solution of 8. This, then, provides the highest proportion of CNT-perylene
hybrids possible. The C50 and CE50 of this CNT perylene mixture were then
calculated from the resulting curve (Table 5).
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PBI C50 ( µM) CE50
PBI (Mean) 0.046 0.07
PBI-CNT Mixture 0.049 0.07
Table 5: Comparison of C50 and CE50 of G1 DAPMA-Terminated PBI 8 (Section 3.1)
and a mixture of this dendrimer with single walled CNTs in a 1 µM to 2.5 mg L−1
ratio.
While this single experiment gives a C50 a little lower than that calculated
as the mean of the assays performed with a 1 µM solution of 8 alone,
the value calculated is within a fraction of the standard deviation of the
earlier experiment (a difference of 0.003 µM, in contrast to a standard
deviation of 0.176 µM). It would be hard to conclude, therefore, that this
experiment demonstrates any significant decrease in the DNA affinity of the
first-generation DAPMA-terminated dendrimer, 8, when bound to carbon
nanotubes.
In order to further probe such DNA-PBI-CNT systems, an additional assay
was performed in which the CNT concentration of the solution was altered
while keeping the concentration of 8 constant. Portions of 0.125 mg L−1 CNTs,
5.08 µM EthBr, 4 µM DNA and 0.05 µM 8 were added to a solution of 5.08
µM EthBr, 4 µM DNA and 0.05 µM 8. This concentration of 8 was chosen due
to its proximity to the C50, reasoning that in this region any fluctuations in
the fluorescence of ethidium bromide, suggesting a reduction or increase in
the DNA affinity of the PBI, would be most visible.
Across a CNT concentration range of 0.06 mg L−1, a slight decrease in
ethidium bromide fluorescence was observed, suggesting an increase in the
strength of DNA binding by 8. Conceivably, this could be attributable to
increased aggregation of perylene units around the carbon nanotubes raising
the degree of self assembled multivalency of the dendrimers. However, as
discussed earlier, the ethidium bromide displacement assay is not a direct
measure of cationic binding, and it may be possible that the polyaromatic
nature of the CNTs introduced into the solution acts to shift the free/bound
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ethidium ion equilibrium in favour of the free form, leading to a reduction in
EthBr fluorescence without an actual increase in the DNA binding capability
of the dendrimer.
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4 Conclusions
The first-generation perylene bisimide dendrimer was, once elements of the
synthesis had been optimised, produced in reasonably high yields. The
remarkably high binding affinity demonstrated by the dendrimer (CE50 =
0.07, though these values are not always comparable between dissimilar
compounds) shows great promise in designing similar, strongly DNA binding
molecules. Previous research into dendritic molecules with aromatic cores
or micelle inducing hydrophobic tails demonstrates the potential for self-
assembled multivalency, and the strong DNA binding that can result from
this. The weaker binding exhibited by the second-generation dendrimer
appeared to lend some support to the idea that self-assembly contributed
to the low C50 and CE50 of these molecules. Despite greater branching and
higher charge per molecule, the G2 DAPMA-terminated dendrimer posessed
a CE50 more than six-times greater than that of the first-generation dendrimer,
or CE50 = 0.46 rather than the G1’s CE50 = 0.07.
It seems highly plausible that some part of this particularly strong binding,
and some part of the difference between first- and second-generation
dendrimers, is attributable to intercalation of the perylene core moieties into
the DNA double helix. This additional binding mode would also cause
displacement of ethidium cations from DNA but may not be beneficial to
efficient DNA packaging, lacking the collapse caused by charge-neutralisation
upon electrostatic binding. This binding mode may also be undesirable in the
formation of three-component nanohybrids, reducing the availability of the
perylene cores for interaction with carbon nanotubes.
As discussed, another method of ascertaining the strength of DNA binding
may be desirable, due to concerns regarding the applicability of the ethidium
bromide displacement assay to these polyaromatic molecules.
While difficult to quantify, the binding of the perylene core to carbon
nanotubes can be indicated qualitatively by the dispersion and solubilisation
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of the CNTs in aqueous buffer. TEM evidence shows that, after deposition
and drying, the nanotubes remain discretely distributed (Figure 38).
Figure 38: Transmission electron micrograph showing an 60,000 x magnification of
the residue from a solution of DAPMA-terminated perylene dendrimer, SWCNTs,
and plasmid DNA.
The addition of CNTs to a solution of DNA and 8 did not appear
to significantly disrupt the binding of DNA, nor cause aggregation and
precipitation of the nanotubes. While a significant shift in the binding affinity
of the dendrimer may have been indicative of a change in the morphology of
the PBI-DNA complexes, statistically it can be presumed that a proportion
of the dendrimer aggregates bind to both DNA and carbon nanotubes.
Indeed, the continued binding of both CNTs and DNA by the first-generation
DAPMA terminated dendrimer suggests the formation of three-component
nanohybrids in solution.
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5 Future Work
5.1 Non-DAPMA Terminated PBIs
Further study of the means by which perylene bisimides cause exclusion of
ethidium bromide is warranted by the possibility of perylene intercalation
into the DNA double-helix, as described in Section 3.2.
The relative contributions of cationic binding and other potential EthBr
displacement modes could be explored through investigation of dendrimers
lacking the DAPMA polyamine functionality. This could consist simply
of carrying out the EthBr displacement assay and UV/Vis intercalation
experiments using the tert-butyl or carboxylic acid terminated dendrimers
described above (compounds 5 and 6 respectively, or 9 and 10 for the second-
generation dendrimer) or of novel molecules that retain the bulk of 8 and
12 while lacking protonatable amines, such as those terminated with alkyl,
polyethylene glycol, or alcohol units.
5.2 Increasing Bulk
Previous studies reported in the literature indicate that perylene bisimides
possessing increased bulk demonstrate reduced intercalation into dsDNA.111
As the second-generation DAPMA-terminated dendrimers described in this
thesis appeared to displace EthBr less efficiently than the less charged first-
generation dendrimers, and as it is presumed that a component of this
displacement results from intercalation, it would seem that increasing the
generation, and thus bulk, of the dendrimers could significantly inhibit this
binding mode. While synthesis of a third-generation DAPMA-terminated
dendrimer would indeed increase this bulk further, the low yields obtained
during the synthesis of 12 would seem to cast some doubt on the viability
of obtaining a G3 DAPMA-terminated perylene bisimide in useful quantities
without significant expenditure of time and material. In addition, such a
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dendrimer would exhibit greater charge and possibly different aggregation
behaviour to the first- and second-generation variants.
An alternative means of increasing steric hindrance around the perylene
moiety would be the synthesis of a “bay-substituted” PBI, in which groups
are added to the 1, 6, 7, or 12 positions of the perylene. (Figure 39).
Either short, highly-branched alkyl groups, or long linear alkyl chains able
to describe a large gyrodynamic radius should reduce the ability of the
dendrimer to intercalate into dsDNA, aiding investigation into the nature of
this interaction, and its contribution to the DNA binding ability demonstrated
by the molecules whose investigation is described in this thesis. However,
once again direct comparison may not be available due to potential changes in
the size and morphology of dendrimer aggregates; if increased bulk around
the dendrimers’ cores inhibits attractive interactions between perylene units,
the resulting reduction in self-assembled multivalency may also lead to a
weakening of the electrostatic DNA binding mode. In addition, increased
bulk around the bay area in such close proximity to the planar perylene
moiety, as well as the resulting twisting of the planar aromatic system, may
hinder CNT binding by the dendrimers, potentially reducing the degree to
which they can solubilise and non-covalently functionalise nanotubes and
participate in the formation of nanohybrids.114
Figure 39: Bay-substituted perylene bisimide, showing functionalisation at the 1, 6, 7
and 12 positions.
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5.3 Potential Sources of Error in the EthBr Exclusion Assay
During the course of the investigations described on previous pages, no
means could be devised by which possible interactions between EthBr and
perylenes could be monitored. As explained in Section 3.3, direct association
between PBIs and ethidium cations in solution could alter the equilibrium
between intercalated and free ethidium, introducing error into the binding
assay. Perylene bisimide dendrimers such as 5 and 9, lacking polyamine units
and so presumably unable to exclude EthBr from DNA via an electrostatic
binding interaction with the DNA, could be modified to introduce additional
bulk, possibly by methods such as those discussed above (Section 5.2). Should
such dendrimers be demonstrated to be unable to intercalate into DNA, any
ethidium bromide displacement measured by assay would, therefore, be the
result of direct perylene-ethidium interactions.
5.4 Newkome-branching, DAPMA-terminated Pyrene Den-
drons
Dendritic pyrenes, represent promising candidates for the efficient binding of
DNA to carbon nanotubes. Should minor synthetic hurdles be overcome,
the resulting dendrons whould presumably bind DNA with affinities at
least as high as those reported previously for Newkome-branching DAPMA-
terminated dendrons lacking the pyrene core.84 A degree of aggregation
may be expected in aqueous solution, resulting in a degree of self-assembled
multivalency that could further improve DNA binding.
The affinity of the pyrene moiety for CNTs has been estalished.39 Comparison
of symmetrical, bolaamphiphilic dendrimers and analogous asymmetrical
amphiphiles by Hirsch et al. suggested that wedge-shaped units able to self-
assemble into micelle-like units demonstrated improved CNT binding relative
to bulky, symmetrical molecules. Accordingly, it would be thought that a
pyrene-based dendron should bind to both carbon nanotubes and DNA to a
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reasonable degree, promoting the formation of nanohybrids.
A practical benefit associated with investigating the DNA binding of pyrene-
containing molecules is that, unlike perylene, its fluorescence emission
reaches a maximum at around 400 nm, with little fluorescence at 595 nm.
Accordingly, difficulties associated with the fluorescence of the dendron
impinging on the observed walvength during EthBr exclusion assays are of
little concern. While neither the absorbance nor fluorescence emission spectra
seem to be as sensitive to aggregation as those of perylene, the formation of
pyrene dendron aggregates could be investigated by TEM, with appropriate
staining.
Figure 40: A first-generation Newkome-branching, DAPMA-terminated pyrene
dendron.
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6 Experimental
Materials and methods
All reagents were commercially available, and used as supplied unless
otherwise stated. Water was de-ionised, and MilliQ water was prepared using
a Millipore Simplicity 185. Boc-DAPMA was synthesised previously by Anna
Barnard, and was used as supplied. TLC was performed on aluminium-
backed plates coated with 0.25 mm silica gel 60, supplied by Merck; spots
were visualised with the naked eye under visible light or under UV, and
with staining where necessary. Column chromatography was performed
using silica gel 60 with a pore size of 0.035 - 0.070 mm, supplied by Fluka.
Size-exclusion chromatography was performed using Bio-Beads R©SX-1 and
Sephadex R©LH-20.
Nuclear magnetic resonance spectroscopy was carried out using two JEOL
400 (1H 400 MHz, 13C 100 MHz) spectrometers. 13C DEPT-135 experiments
were performed where necessary. Chemical shifts (δ) are reported in parts
per million (ppm) downfield of tetramethylsilane (TMS) and residual solvent
was used as an internal reference (CHCl3: 7.26 ppm & 77.16 ppm, MeOH:
3.31 ppm & 49.00 ppm, pyridine: 7.29 ppm). Electrospray Ionisation (ESI)
and Atmospheric Pressure Chemical Ionisation (APCI) mass spectrometry
were recorded using a Bruker micrOTOF MS. Matrix-assisted laser desorption
ionisation (MALDI) mass spectrometry was recorded using a Bruker Ultraflex
II MALDI-TOF/TOF mass spectrometer, with 2,5-dihydroxybenzoic acid
(DHB) as the matrix. Infrared spectra were recorded using a JASCO FT/IR-
4100 and values are expressed in cm−1, while UV/Vis spectra were recorded
using a Shimadzu UV 2401PC, with values expressed in nm. Fluorescence
spectroscopy was carried out using a Hitachi F-4500 Fluorimeter, exciting at
280 nm and observing emission at 595 nm unless otherwise stated.
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SHE Buffer
0.01 M SHE buffer was prepared from 1 M HEPES (0.5 ml, 0.5 mmol),
trisodium EDTA (0.0035 g, 0.009 mmol) and NaCl (2.194 g, 37.54 mmol) in
MilliQ water (250 ml).
Ethidium Bromide Displacement Assay
All calculations described herein involving calf thymus DNA take the
fundamental unit as one base pair residue, containing two nucleotides, two
phosphate groups, and two deoxyribose residues. The average mass of this
unit is taken to be 660 Da.
Calf thymus DNA (0.001 g, 0.0015 mmol) was dissolved in 0.01 M SHE buffer
(75 ml) to give a 40 µM stock solution. A portion (10 ml) was then further
diluted with SHE buffer (40 ml) to give an 8 µM solution. Ethidium bromide
(0.005 g, 0.013 mmol) was dissolved in SHE buffer (50 ml) to give a 25.4
µM stock solution. A portion (20 ml) was then further diluted with SHE
buffer (30 ml) to give a 10.16 µM solution. Portions of each were mixed in
in a 1:1 ratio to give a solution of 4 µM DNA and 5.08 µM EthBr. To this
was titrated portions of the solution under investigation, prepared following
the procedures outlined below. Fluorescence spectra of these titrations were
measured, exciting the samples at 280 nm and observing the emission at
595 nm. The initial fluorescence emission was normalised to 1, while the
minimum was normalised to 0.
Preparation of PBI-DAPMA Solutions for Ethidium Bromide
Exclusion Assay
Due to the small quantities of material required, in all cases stock solutions
of the dendrimer were prepared in MeOH to a known concentration.
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The desired volume of solution was then removed using an adjustable
micropipette, transferred to a clean vial, and the solvent removed in vacuo
to give a red film. This solid residue was then dissolved in the appropriate
volume of 4 µM DNA and 5.08 µM EthBr in 0.01 M SHE buffer, prepared as
above, in order that the DNA and ethidium bromide concentrations remain
constant throughout the course of the titration. The solutions were then used
in the exclusion assay, as described above.
Intercalation Study
A stock solution of the dendrimer was prepared in MeOH to a known
concentration. The desired volume of solution was then removed using an
adjustable micropipette, transferred to a clean phial, and the solvent removed
in vacuo to give a red film. This solid residue was then dissolved in the
appropriate volume of a 57.47 µM DNA solution , to give a 1 µM solution
of the perylene. An equivalent 1 µM solution of the perylene was prepared
using 0.01 M SHE buffer, rather than the DNA solution.
The UV/Vis absorbance of the perylene solution in buffer was measured.
Portions of the DNA/perylene solution were then added by micropipette,
and the absorbance after each successive addition was recorded relative to
the DNA concentration. Data were then normalised according to the UV/Vis
absorbance of equivalent calf thymus DNA dilutions in 0.01 M SHE buffer.
Preparation of CNT Solutions
Single-walled carbon nanotubes (0.09 mg) were weighed into a vial, to
which was added 10 µM G1-PBI-DAPMA in 0.01 M SHE buffer (2 ml) via
micropipette. After sonication for 2 hours, homogenous red-grey solution
had formed: CNTs (0.045 g L−1) in 10 µM G1-PBI-DAPMA. Centrifugation
at 4500 rpm for 45 minutes afforded a pale red solution over dark material.
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Sonication restored the liquid to a homogenous red-grey solution, which was
stable after one week, with minimal aggregation. After three months, some
settling of black material was observed but the solution was easily restored
by shaking, with no need for further sonication.
Titration of CNT Solutions
The 0.045 g L-1 solution of CNTs in 10 µM G1-PBI-DAPMA, prepared as
described above, was titrated into 10 µM G1-PBI-DAPMA in 0.01 M SHE
buffer (2ml) in a quartz cuvette. The UV/Vis absorbance of the resulting
dilutions was measured. In order to probe possible changes in the absorbance
of the perylene moiety upon CNT binding, data were normalised according to
the UV/Vis absorbance of equivalent CNT solutions in SDBS. The solutions
were prepared from a 0.1 g L−1 solution of CNTs in SDBS, itself prepared
from SWCNTs (0.7 mg) and SDBS (2.4 mg, 0.007 mmol) in 0.01 M SHE buffer
(7 ml).
Transmission Electron Microscopy
TEM studies were carried out using an FEI Technai 12 Biotwin at 120 kV,
using a copper grid on a Formvar and carbon support. Samples were placed
on the grid in solution, left for 3 minutes, and excess liquid removed. Samples
were then stained using uranyl acetate (1 % in water) and left for a further
10 minutes before excess stain was removed and imaging was carried out.
Samples consisted of: a 10 µM solution of G1-PBI-DAPMA containing 0.045
g L−1 CNT; a further portion of the same, centrifuged and the supernatant
diluted by a factor of 10 using 0.01M SHE buffer before the addition of 0.01 g
L−1 plasmid DNA; a 1:1 mixture of these two samples.
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Di-tert-butyl 4-(3-tert-butoxy-3-oxopropyl)-4-nitroheptanedioate
(1)80
A solution of nitromethane (0.87 ml, 16.4 mmol) and Triton B (0.16 ml, 0.36
mmol) was stirred in THF (3.5 ml) at 60◦C. tert-Butyl acrylate (7.4 ml, 51
mmol) was added dropwise in order to minimise any temperature increase;
the temperature was monitored and kept below 70◦C. After several minutes,
two further portions of Triton B (each 0.16 ml, 0.36 mmol) were added. The
yellow solution turned orange. The reaction was stirred for 1.5 h, after which
the solvent was removed in vacuo, and the residue dissolved in chloroform (40
ml). The solution was washed with 10% aqueous HCl (10 ml), then with three
portions of brine (each 10 ml). The organic phase was dried over magnesium
sulfate and then filtered. The solvent was removed in vacuo and the residue
recrystallised from ethanol. The resulting white crystals were recovered in
two crops.
Yield 4.47 g (61 %). 1H NMR (CDCl3, 400 MHz) δ 1.43 (s, CH3, 27H); 2.19
(s, CH2, 12H). 13C NMR (CDCl3, 100 MHz) δ 28.16 (CH3, 9C); 29.93 (CH2CO,
3C); 30.47 (CCH2, 3C); 81.29 (C(CH3)3, 3C); 92.32 (O2NC, 1C); 171.21 (CO,
3C). ESI-MS (m/z): 468.26 (100%, [M+Na]+).
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Di-tert-butyl 4-amino-4-(3-tert-butoxy-3-oxopropyl)heptanedioate
(2)80
A slurry of 50% w/w Raney nickel in water (4.1 g, 34.93 mmol) was mixed
with EtOH (25 ml). The resulting suspension was allowed to settle, and the
supernatant was decanted. This procedure repeated twice more in order to
obtain a suspension of Raney nickel in EtOH. This suspension was rinsed into
the flask with a further portion of EtOH (50 ml). 1 (4.5 g, 10.10 mmol) was
added. The flask was purged with nitrogen, then hydrogen. The solution
was then stirred vigorously under hydrogen at 45 ◦C for 23 h, before being
filtered over Celite and rinsed with MeOH. The solvent was then removed
in vacuo at no more than 30 ◦C to give a translucent oil which, after several
hours, became a white solid. No further purification was carried out, and the
product was stored under nitrogen at -18 ◦C until required.
Yield 4.1 g (98 %). 1H NMR (CDCl3, 400 MHz) δ 1.14 (br s, NH2, 2H); 1.39 (s,
CH3, 27H); 1.56 (t, CH2, J = 8.4 Hz, 6H); 2.20 (t, CH2, J = 8.4 Hz, 6H). 13C NMR
(CDCl3, 100 MHz) δ 28.11 (CH3); 30.00 (CH2); 34.40 (CH2-CO); 52.38 (H2NC);
80.34 (C(CH3)3); 173.10 (CO). ESI-MS (m/z): 416.30 (100%, [M+H]+).
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di-tert-butyl 4-(6-(benzyloxycarbonylamino)hexanamido)-4-(3-
tert-butoxy-3-oxopropyl)heptanedioate (3)
2 (0.33 g, 0.79 mmol), Z-caproic acid (0.27 g, 1.02 mmol) and TBTU (0.29 g,
0.90 mmol) were dissolved in DCM (15 ml) and cooled in ice. DIPEA (0.31
ml, 1.78 mmol) was added, with stirring. The solution was then stirred for
16 hours, slowly warming to room temperature, after which it was stirred at
reflux for 11 days. During this time the reaction was monitored by TLC. The
solvent was then removed in vacuo, and the residue redissolved in DCM (20
ml). This solution was then washed with water (40 ml), 1 M HCl (40 ml), 1
M Na2CO3 (40 ml), and then two further portions of water (2 x 40 ml). The
solution was dried over MgSO4, then filtered. The solvent was removed in
vacuo and the resulting solid redissolved in 2:3 cyclohexane:EtOAc, before
being eluted with the same over SiO2. Solvent was removed in vacuo to
give a solid, which was then redissolved in DCM and washed with NaHCO3
in order to remove an aromatic impurity. The solvent was then once more
removed in vacuo.
Yield 0.35 g (70 %). R f = 0.65 (2:3 cyclohexane:EtOAc on SiO2). 1H NMR
(CDCl3, 400 MHz) δ 1.24 (m, CH2, 2H); 1.34 (s, CH3, 27H); 1.245 (m, CH2,
2H); 1.52 (m, CH2, 2H); 1.88 (t, CH2, J = 8.0 Hz, 6H); 2.02 (t, CH2, J = 7.2 Hz,
2H); 2.13 (t, CH2, J = 8.0 Hz, 6H); 3.10 (q, CH2, J = 6.4 Hz, 2H); 4.95 (br s,
NH, 1H); 5.00 (s, C6H5-CH2-O, 2H); 5.86 (s, NH, 1H); 7.23 (m, C6H5, 5H). 13C
NMR (CDCl3, 100 MHz) δ 25.35 (CH2, 1C); 26.42 (CH2, 1C); 28.17 (CH3, 9C);
29.74 (CH2, 1C); 29.95 (CH2, 3C); 30.05 (CH2, 3C); 80.84 (C(CH3)3, 3C); 128.22,
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128.61, 129.09, 136.76 (C6H5, 6C); 156.54, 172.49 (CONH, 2C); 173.07 (COOtBu,
3C). ESI-MS (m/z): 663.42 (25%, [M+H]+), 685.40 (100 %, [M+Na]+).
Di-tert-butyl 4-(6-aminohexanamido)-4-(3-tert-butoxy-3-oxopropyl)
heptanedioate (4)80
3 (0.35 g, 0.53 mmol) was dissolved in a sufficient volume of hot EtOH. 10
% palladium over carbon (0.05 g, 0.05 mmol) was added, with stirring. The
flask was purged with nitrogen, then put under hydrogen and stirred at room
temperature for 24 hours. The solution was then filtered over Celite, rinsed
through with further EtOH. The solvent was then removed in vacuo to afford
a clear film.
Yield 0.24 g (86 %). 1H NMR (CDCl3, 400 MHz) δ 1.10 (m, NH, 1H); 1.30
(m, CH2, 2H); 1.39 (s, CH3, 27H); 1.57 (m, CH2, 2H); 1.92 (t, CH2, J = 7.6
Hz, 6H); 2.08 (t, CH2, J = 7.2 Hz, 2H); 2.17 (t, CH2, J = 7.6 Hz, 6H); 2.65 (m,
CH2, 2H); 5.98 (m, NH, 1H). 13C NMR (CDCl3, 100 MHz) δ 25.59, 26.54 (CH2,
2C), 28.15 (CH3, 9C); 29.91 (CH2, 3C); 30.04 (CH2, 3C); 33.34 (CH2, 1C); 37.46
(CH2, 1C); 42.02 (CH2, 1C); 57.37 (CONH-C-R3); 80.74 (C(CH3)3, 3C); 172.53
(CONH, 1C); 173.01 (COOtBu, 3C). ESI-MS (m/z): 529.38 (100%, [M+H]+).
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G1 Newkome Branching tert-Butyl Terminated Perylene
Bisimide (5)95
4 (0.24 g, 0.45 mmol), perylene tetracarboxylic acid dianhydride (0.092 g, 0.23
mmol), imidazole (1.5 g, 22 mmol), and zinc acetate (0.027 g, 0.15 mmol) were
added to a flask, which was then heated to 110 ◦C with stirring. Upon melting
of the imidazole, the resulting solution was stirred for 18 hours. Periodically,
it was necessary to dislodge white needle-like crystals of imidazole forming
in the top of the flask, in order to return them to the reaction volume. The
solution was allowed to cool to room temperature and the resulting solid was
dissolved in 95:5 DCM:MeOH. This was then eluted over silica with the same
mixture of DCM and MeOH, to afford a red solid.
Yield 0.27 g (81 %). R f = 0.56 (95:5 DCM:MeOH on SiO2). 1H NMR δ 1.26
(m, NH, 1H); 1.42 (s, CH3, 54H); 1.48 (m, CH2, 4H); 1.74 (m, CH2, 8H); 1.97
(t, CH2, J = 8.0 Hz, 12 H); 2.16 (t, CH2, J = 7.8 Hz, 4H), 2.22 (t, CH2, J = 8.0
Hz, 12H); 4.20 (t, CH2, J = 7.6, 4H); 5.87 (s, NH, 1H); 8.56 (d, Ar-H, J = 8.4 Hz,
4H); 8.65 (d, Ar-H, J = 8.0 Hz, 4H). 13C NMR δ 25.50 (CH2, 2C); 26.73 (CH2,
2C); 27.59 (CH2, 2C); 28.16 (CH3, 18C); 29.91 (CH2, 6C); 30.01 (CH2, 6C); 37.27
(CH2, 2C); 40.42 (CH2, 2C); 57.45 (CN, 2C); 80.72 (C(CH3)3, 6C); 122.76, 122.97,
125.64, 128.80, 130.89, 133.84 (Ar, 20C); 162.96 (CON, 4C); 172.81 (CONH,
2C); 173.01 (COOR, 6C). ESI-MS (m/z): 1436.7 (100 %, [M+Na]+). APCI-MS
(m/z): 1077.40 (100 %, [M+H, -6tBu]+).
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G1Newkome-Branching Carboxyl Terminated Perylene Bisimide
(6)95
5 (0.25 g, 0.162 mmol) was dissolved in formic acid (20 ml) and stirred at
room temperature for 21 hours. The solvent was then removed in vacuo. The
resulting red solid was then put under a small volume of toluene, which was
removed in vacuo in order to remove residual formic acid as an azeotrope.
Yield 0.23 g (Quantitative yield). 1H NMR (CDCl3/d5-pyridine, 400 MHz) δ
1.63 (s, CH2, 4H); 2.00 (s, CH2, 8H); 2.54 (m, CH2, 4H); 2.74 (s, CH2, 12H);
2.91 (s, CH2, 12H); 4.40 (s, CH2, 4H); 8.16, 8.18, 8.43 (m, Ar-H, 8H). 13C
NMR (CDCl3/d5-pyridine, 100 MHz) δ 25.29 (CH2, 2C); 26.47 (CH2, 2C); 27.37
(CH2, 2C); 29.82 (CH2, 12C); 36.26 (CH2, 2C); 39.79 (CH2, 2C); 54.18 (CH2N,
2C); 57.02; 122.11, 124.69, 12.86, 132.94 (Ar, 20C); 162.20 (CON, 4C); 172.16
(CONH, 2C); 175.28 (COOH, 6C). ESI-MS (m/z): 1077.39 (100 %, [M+H]+).
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G1 Newkome-Branching Boc-DAPMA-Terminated Perylene
Bisimide (7)
6 (0.095 g, 0.088 mmol) was dissolved in DCM (20 ml) and pyridine (20 ml).
To this solution was added DIPEA (0.2 ml, 1.148 mmol), TBTU (0.189 g, 0.589
mmol), and DMAP (0.034 g, 0.278 mmol) with stirring. This was followed
by Boc-DAPMA (0.407 g, 1.659 mmol), an oily gum that was dissolved in
a small quantity of DCM and rinsed into the reaction vessel with a further
portion of DCM. The translucent red solution was then put under nitrogen
in order to minimise absorption of water from the air, and then stirred for 7
days. The progress of the reaction was monotired by TLC in 99:1 MeOH:Et3N,
with the product or a mixture of partially-substituted products appearing
as a smeared region encompassing the length of the plate. This was in
contrast to the starting material which failed to move from the baseline under
these conditions. Solvent was removed in vacuo and the resulting red solid
dissolved in the minimum quantity of DCM. The solution was then purified
by size-exclusion chromatography over Bio-Beads R©, eluting with DCM. A
small quantity of red material remained at the top of the column, with the
remainder passing through at various rates. As would be expected, the larger,
more completely substituted material was present in the earliest fractions.
These were recombined, the solvent removed in vacuo, and the the resulting
red solid redissolved in DCM. Residual aromatic impurities were present in
this material, some but not all of which was removed by a repeat of the
size-exclusion chromatography procedure described above. Once again, the
earliest, more pure, fractions were recombined and the solvent removed in
vacuo. Finally, the remainder of the impurites were removed by further size-
exclusion chromatography, this time eluting over Sephadex R©with MeOH.
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The resulting pure fractions were recombined and condensed in vacuo to
give a red solid, which was further dried by lypohilisation: the solid was
dissolved in tBu-OH, freezed with liquid nitrogen, and the solvent was then
sublimed in vacuo.
Yield 0.053 g (26 %). 1H NMR (d-MeOD, 400 MHz) δ 1.41 (s, CH3, 54H); 1.72,
1.95 (m, CH2, 40 H); 2.25 (s, CH2, 12H); 2.87, 3.02, 3.13 (m, CH2, 52H); 3.27 (p,
CH3, J = 1.6 Hz, 18H); 3.99 (s, CH2, 4H); 5.46 (s, NH, 12H), 7.94 (br m, Ar-H,
8H). 13C NMR (MeOD, 100 MHz) δ 27.50 (CH3, 18C), no other chemical shifts
visible. ESI-MS (m/z): 814 (37 %, [M+3H]3+), 611 (100 %, [M+4H]4+]).
G1Newkome-Branching DAPMA-Terminated Perylene Bisimide
(8)
7 (0.053 g, 0.023 mmol) was dissolved in methanol (10 ml). With stirring,
gaseous HCl was then bubbled through the deep-red solution for 40 seconds.
Some cloudiness was observed in the solution. After 23 hours, stirring was
ceased and the precipitate allowed to settle, affording an orange solution over
a deep-red or brown precipitate. The solvent was removed in vacuo to give a
red brown residue which was fully soluble in pure MeOH. The solvent was
then once again removed in vacuo to give the solid.
Yield 0.044 g (86 %). 1H NMR (d-MeOD, 400 MHz) δ 1.21, 1.41, 1.66, 2.02,
2.12 (br m, CH2, 52H); 2.86, 2.94, 3.01, 3.10 (br m, CH2, 60H); 3.24 (p, CH3, J
= 1.6 Hz, 18H); 3.63 (s, CH2, 4H); 7.99 (br m, Ar-H, 8H). 13C NMR (MeOD,
100 MHz) δ 23.49 (CH2); 37.89 (CH2); 40.59 (CH2); 49.85 (CH3); 54.38 (CN).
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ESI-MS (m/z): 921 (34 %, [M+2H]2+]), 614 (100 % [M+3H]3+), 461 (85 %
[M+4H]4+), 369 [69 % [M+5H]5+).
G2 Newkome Branching tert-Butyl Terminated Perylene
Bisimide (9)
6 (0.095 g, 0.088 mmol) was dissolved in DCM (10 ml) and pyridine (10 ml).
2 (0.254 g, 0.611 mmol) and TBTU (0.184 g, 0.573 mmol) were added, with
stirring. To this solution was added DIPEA (0.2 ml, 1.148 mmol). The opaque
red solution was put under nitrogen in order to minimise the absorption of
water from the air. In an attempt to improve the solubility of the components,
THF (5 ml) and a further quantity of DCM (5 ml) were added. The progress
of the reaction was monitored by TLC. After 11 days, the cloudy red-brown
solution was condensed in vacuo and the resulting solid redissolved in the
minimum quantity of DCM. This solution was then washed with 1.33 M
NaHSO4 (20 ml), saturated NaHCO3 (20 ml), water (20 ml) and, finally, brine
(20 ml). The solvent was then removed in vacuo, the product redissolved in
EtOAc, and then purified by eluting with the same over SiO2 to give a red
solution. The solvent was once again removed in vacuo to give a red solid.
Yield 0.097 g (32 %). R f = 0.94 (EtOAc on SiO2). 1H NMR (CDCl3, 400 MHz)
δ 1.20 (s, 20H), 1.37 (s, CH3, 162H + m, CH2, 4H); 1.67 (m, CH2, 4H); 1.77 (m,
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CH2, 4H); 1.91 (m, CH2, 48H); 2.16 (t, CH2, J = 8.0 Hz, 52H); 4.17 (t, CH2, J
= 6.5 Hz, 4H); 6.19 (br m, NH, 6H); 7.29 (br s, NH, 2H); 8.60 (br m, Ar-H,
8H). 13C NMR (CDCl3, 100 MHz) δ 22.73, 25.26, 26.68 (CH2, 6C); 28.13 (CH3,
54C); 29.73, 29.85 (CH2, 36C); 31.73, 31.88 (CH2, 12C); 36.94 (CH2CO, 2C);
40.56 (CH2, 6C); 57.51 (CN, 6C); 57.83 (CN, 2C); 80.55 (C(CH3)3, 18C); 120.21,
123.28, 125.11, 128.82, 131.52 (Ar, 20C); 163.43 (CON, 4C); 172.73 (COOR,
18C); 173.00 (CON, 6C); 173.22 (CONH, 2C). ESI-MS (m/z): 1732 (100 %,
[M+2H]2+), 1155 (82 %, [M+3H]3+).
G2Newkome Branching Carboxyl Terminated Perylene Bisimide
(10)
9 (0.097 g, 0.088 mmol) was dissolved in formic acid (5 ml). After 24 hours,
residue on the inside of the flask was washed into the formic acid with DCM
(3 ml). After a further 18 hours the solvent was removed in vacuo, and
residual formic acid was removed as an azeotrope by dissolving the red solid
in a mixture of methanol and toluene, which was then removed in vacuo.
Yield 0.068 g (99 %). 1H NMR (MeOD/d5-pyridine, 400 MHz) δ 1.19 1.49,
1.77, 1.94 (m, CH2, 12H); 2.30, 2.40, 2.51 (m, CH2, 100H); 4.22 (br s, CH2,
4H); 8.18 (br m, Ar-H, 8H). 13C NMR (MeOD/d5-pyridine, 100 MHz) δ 29.40,
30.59, 30.74, 32.05, 35.79 (CH2); 58.72 (CN); 175.67, 177.31 (OCNH). UV/Vis
(MeOH): λmax = 490 nm, 523 nm.
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G2 Newkome-Branching Boc-DAPMA-Terminated Perylene
Bisimide (11)
10 (0.068 g, 0.028 mmol) was dissolved in a mixture of DMSO (3 ml) and
pyridine (2 ml) affording a deep-red solution. To this was added TBTU (0.205
mg, 0.638 mmol) and DMAP (0.034 g, 0.28 mmol). Boc-DAPMA (0.370 g,
1.508 mmol) was added dissolved in DMSO (2 ml) and DCM (2 ml). Initially,
a small quantity of undissolved white powder was visible. After stirring
for 5 minutes all components appeared to have dissolved, at which point
DIPEA (0.2 ml, 1.148 mmol) was added. The progress of the reaction was
monitored by TLC (99:1 MeOH:Et3N on SiO2). After 14 days, the solution
was gently heated to encourage evaporation of the DCM. The remaining
solvent was then removed by vacuum distillation. The resulting solid was
then redissolved in DCM, which was removed in vacuo. Subsequent heating
to 110 ◦C in vacuo was carried out in order to remove residual DMSO. The
red solid was then dissolved in DCM (100 ml) and filtered to remove insoluble
impurities, before being once again condensed in vacuo and then redissolved
in DCM (20 ml) to give a dark red solution. This was then purified by
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size-exclusion chromatography by eluting over BioBeads R©with DCM. The
fractions with highest R f were then condensed in vacuo, dissolved in MeOH,
and then further purified by additional size-exclusion chromatography over
Sephadex R©, eluting with MeOH.
Neither ESI nor MALDI-TOF mass spectrometry showed the desired product.
13C NMR did not show any chemical shifts other than those attributable to
the solvent, despite use of a high number of scans and extended relaxation
delay.
Yield 0.004 g (2 %). 1H NMR (MeOD, 400 MHz) δ 1.39 (s, CH3, 162H); 1.84,
1.96, 2.19 (br m, CH2, 162H); 2.66 (br s, CH2, 6H); 2.92, 3.13 (br m, CH2, 40H)
3.27 (p, CH3, J = 1.6 Hz, 54H); 3.48 (s, CH2, 36H); 7.67 (br m, Ar-H, 8H).
UV/Vis (MeOH): λmax = 490 nm, 523 nm.
G2Newkome-Branching DAPMA-Terminated Perylene Bisimide
(12)
11 (0.004 g, 0.0006 mmol) was dissolved in methanol (5 ml). With stirring,
gaseous HCl was then bubbled through the deep-red solution for 40 seconds.
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Some cloudiness was observed in the solution. After 19 hours, the solvent
was removed in vacuo to give a red solid. This was observed to be partially
soluble in neutral MeOH, forming a pale-red or pink solution containing an
insoluble red film suspended within.
Insufficient product was produced to obtain characterization by NMR.
Yield 0.004 g (Quantitative yield). UV/Vis (0.01 M SHE buffered water): λmax
= 499 nm, 543 nm.
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